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INTRODUCTION 
Dietary protein offers strong protection in some toxicoses of drugs, 
pesticides, minerals and natural toxicants (Hathcock, 1976). The protec­
tive .effect of dietary protein is partially related to the sulfhydryl 
containing amino acids such as cysteine and methionine. Dietary protein 
deficiency may increase the toxicity of heavy metals (Hathcock, 1976). 
High cysteine content of intestine, xiver, and kidney metallothionein, 
a ligand which buffers heavy metal ion concentration (Cousins, 1979) 
suggests that deficiency of sulfur amino acids may increase heavy metal 
toxicity through limitation of metallothionein synthesis. 
Both cysteine and methionine are the precursors of glutathione, a 
non-protein thiol compound which is present in all types of cells. 
Besides its reducing capability as a protective mechanism against 
hyperoxides, and other functions in the cell, glutathione conjugates 
histotoxic metabolites of certain drugs and toxicants (Arias and Jakoby, 
1976). 
Humans are surrounded with a world of chemicals. Each year 500-
1000 new compounds are produced in commercial quantities (Damstra, 1978). 
Increases of population, industrialization and use of pesticides in food 
production results in human exposure to many different chemicals. Many 
industrial and agricultural chemicals may enter the environment as 
waste products, are discharged into the air, rivers, and lakes, and 
some eventually find their way into humans through contaminated food, 
water, and air. 
Because of its extreme toxicity, multiple sources and several 
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accidental poisonings, methylmercury has been carefully studied with 
regard to its effect on human health and quality of life (Clarkson, 
1976). There is a progressive increase in general background level of 
mercury in the industrialized societies. In addition to the emission 
of mercury through fossil fuel burning (Joensun, 1971), the extensive 
use of mercury in ccxmnercial and agricultural production- adds signifi­
cant quantities of mercury to the human environment (Lutz, 1967). The 
potential health hazard of methylmercury to laboratory and industrial 
workers has been recognized for many years, and disastrous outbreaks of 
methylmercury poisoning have occurred in Japein and Iraq in recent decades 
(Rowland et al., 1977; Bakir et al., 1973). 
Atrazine is a herbicide which, due to its low toxicity, is widely 
used in agriculture. Its residues persist in the environment and in 
plants for a long period of time (Dalgaard-Mikkelsen and Poulsen, 1962). 
Methylmercury is detoxified in the body in conjugation with cysteine 
and glutathione. Atrazine is also detoxified by conjugation with 
glutathione and is excreted in urine as mercapturic acid. Since cysteine 
and methionine are the precursors of glutathione, their dietary content 
of protein would be important with regard to chronic exposure of humans to 
these toxicants. 
In general, methionine and cysteine are high in animal proteins but. 
plants are poor sources of these sulfur amino acids. Soybeans, which are 
considered an excellent source of protein, contain protein in which 
methionine is distinctly the first-limiting amino acid. With increasing 
use of soybean or other legume seed products as meat extenders or re-
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placers, the sulfur amino acid content of many diets may become more 
marginal. Therefore, studying the role of diets containing various 
levels of sulfur amino acids in the detoxification of methylmercury 
and atrazine can provide valuable information for establishing acceptable 
levels of these two toxicants and for setting dietary requirements of 
proteins (both quality and quantity). 
The purpose of this study is to investigate the effect of supple­
mentation of diet with excess methionine on toxicity of methylmercury 
hydroxide and/or atrazine and also to study the synergistic effects of 
atrazine on methylmercury toxicity. Biochemical as well as behavioral 
changes due to different treatments were measured for these purposes. 
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REVIEW OF LITERATURE 
Toxicology of Methylmercury 
Methylmercury (MeHg) poisoning has occurred in two distinct 
situations. One has occurred as a result of industrial waste products 
with inorganic mercury being discharged into the sea or rivers. The 
inorganic mercury was then converted to organic mercury compounds by 
small aquatic organisms and accumulated in higher trophic levels such as 
fish and shellfish (Hamdy and Prabhu, 1979). The consumption of such 
contaminated fish and shellfish resulted in poisoning. This occurred 
in Minamata Bay in 1953 and in Niigata in 1965 in Japan (Rowland et al., 
1977; Kutsuma, 1968; Kurland et al., 1960). The syndrome of short-chain 
alkyMercurials poisoning is, therefore, called the Minamata disease. MeHg 
and ethylmercury are often grouped together as shortrchazLn alky Mercurials. 
Other large outbreaks have occurred as a result of accidental consumption 
of grain treated with MeHg as a fungicide. This occurred in a major 
episode in Iraq in 1971 (Bakir et al., 1973; Skerfving and Copplestone, 
1976). The organomercurial seed-dressing compounds protect the seed from 
a wide range of fungi and have a low toxicity to the seed. At least 6500 
people were affected with 459 recorded deaths in Iraq (Bakir et al., 1973). 
The syndrome of poisoning by short-chain alkyMercurials, 
Minamata disease, is characterized by paresthesia of the hand, foot, lips 
and tongue, by ataxia and by concentric constriction of visual fields 
(Skerfving and Vostal, 1972; Al-Damluji, 1976). 
MeHg is a potent neurotoxin; the clinical patterns of organic and 
inorganic mercury poisoning are very different. Organic mercury affects 
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mainly the nervous system and produces neurological disease. Inorganic 
mercury affects gastrointestinal, renal and nervous systems, stomata and 
gingivi (Neal and Jones, 1938). 
A limited conversion of inorganic mercury to alkylmercury in the 
body is possible. Rowland et al. (1977) demonstrated that bacterial 
flora .of rat gut contents synthesized MeHg from mercuric chloride in 
vitro, and their estimation for the total amount of MeHg synthesized 
for ingested inorganic mercury in man was approximately 400 ng/day. 
Inversely, the biotransformation of alkylmercury to inorganic mercury 
in the body is also possible. Jacob et al. (1975) and Magos and Butler 
(1976) suggested that biotransformation of some forms of organic 
mercury to inorganic form is responsible for the toxicity of organic 
mercurials, and liver is the major site. Gallagher and Lee (1980), 
however, found that the biotransformation is not the only mechanism by 
which organic mercury exerts its toxicologic effects. 
The chemical properties of MeHg (CH^Hg"*") and mercuric mercury (Hg"*"*") 
are quite different. MeHg is monofunctional, so that it can react 
with only one ligand to give CH^Hg-ligand complex, whereas Hg"*"*" is 
bifunctional and it can react with two ligands to form ligand-Hg-ligand 
complex. Therefore, their behavioral differences in absorption, trans­
portation, translocation and accumulation, and in general, toxic effects 
are related to these chemical properties. 
MeHg is known to have a great affinity for sulfhydryl groups (-SH) 
and it is causes a decrease in -SH groups in the brain and liver of 
the rat (Pekkanen and Sandholm, 1971). Hirayama (1975) demonstrated that 
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MeHg makes complexes with cysteine through the -SH group of cysteine; the 
amino acid portion of the structure remains intact and acts as an active 
carrier of MeHg across membranes, including the blood brain barrier 
(BBB). Therefore, MeHg can be easily absorbed, transported, and distrib­
uted. On the contrary, Hg"*^ ion not only chelates the -SH group, but it 
also binds to other groups like -NH^ and -COOH of cysteine. Since Hg""^ 
can make a complex with two ligands simultaneously, it is not easily 
transported across the BBB, and this is why neurological effects of 
inorganic mercury compounds are not predominant. 
The BBB is considered to be a con^lex of multiple systems regulating 
the exchange of metabolic materials between brain and blood (Steinwall 
and Klatzo, 1966; Lajtha, 1962). Amino acids enter into the brain 
through the BBB. Oldendorf and Szabo (1976) stated that the BBB transport 
of amino acids has been attributed to three independent transport systems : 
neutral, basic and acidic systems, similar to that in the intestine. The 
active transport of cysteine in the BBB contributes to the uptake of 
MeHg-cysteine complex in the brain (Hirayama, 1980). Hirayama (1980) 
also studied the effect of amino acids other than cysteine on brain uptake 
of MeHg, and found that the brain uptake of MeHg was depressed by phenylal­
anine and isoleucine which are neutral amino acids and not by lysine and 
glutamine which are basic and acidic amino acids, respectively. Depression 
of MeHg uptake of the brain by phenylalanine and isoleucine was attributed 
to the cross inhibitory effect of amino acids, which belong to the same 
carrier transport systeir. (Oldendorf and Szabo, 1876) . 
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Hirayama (1975) found that after subcutaneous administration of 
WeHg chloride to rats fed on a low cysteine diet, the brain showed sig­
nificantly lower mercury levels than those of controls, but liver mercury 
levels were significantly higher than those of controls. Chang and Hart­
mann (1972a,b) observed dysfunction of rat BBB in mercury toxicosis and 
believed it to be due to an impairment of the endothelial and glial 
membrane by mercury. The impairment of the BBB has also been reported in 
o'thsr heavy metal toxicoses such as lead poisoning (Pentschow and Carro, 
1966). Chang and Hartmann (1972a) also indicated that impairment of the 
BBB after mercury administration is responsible for the great reduction 
of the brain uptake of amino acids and other metabolites. Therefore, the 
neurotoxic effects of mercury on the central nervous system mainly depend 
on BBB function and the nature of the mercury compound. It is possible 
that at the early stages of mercury toxicosis, the presence or absence of 
sulfur amino acids might affect brain uptake of mercury and that later on, 
after BBB impairment, its uptake is not carrier dependent and might not 
be affected by the changes in the level of sulfur amino acids. The 
effect of MeHg upon nervous tissue is associated with the disturbance of 
protein synthesis ^  vitro (Yoshino et al., 1966) and ^  vivo (Cavanagh 
and Chen, 1971). Studies have shown the impairment of the incorporation 
of labeled amino acids into protein. Ultrastructurally MeHg appears 
to have a direct effect upon ribosomes in nerve cells (Herman et al., 
1973; Jacob et al., 1977). The loss of protein synthesizing capabil­
ity of the nerve cell may lead to its death. 
Sulfhydryl groups are essential to the structural and functional 
integrity of cell membranes. Disturbance in the cell membrane function 
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may produce biochemical changes. Because the mercurials have a high 
affinity to the -SH group, and membranes contain -SH groups, membrane 
disturbance by mercurials is more likely. It was speculated that membrane 
permeability and enzymes which are located in the membrane were affected 
by mercurials (Clarkson, 1972). 
In a repeated exposure of rats to MeHg, Magos and Butler (1976) 
found that the accumulation of mercury in kidney and blood was distinctly 
higher than that of other organs. The proportion of inorganic to total 
mercury remained as low as 5% in whole body, whereas in the kidney 
with increasing doses a higher proportion of mercury was in the inorganic 
form. They also stated that weight loss, change in kidney function and 
enterohepatic circulation of MeHg might also have contributed to a 
redistribution of mercury. 
The injection of a single dose of MeHg hydroxide in mice and rats 
resulted in a high accumulation of mercury in the kidney, blood, and liver 
respectively (Ulfvarson, 1969a; 1969b). Mercury also binds to metallo­
thionein in the liver and kidney. Methallothionein is a low molecular 
weight protein which is rich in -SH groups. It has been demonstrated 
that mercury causes an increase of metallothionein in the liver and kidney 
(Piotrowski et al., 1974; Winge et al., 1975). The binding of mercury 
to metallothionein has been shown to be influenced by the level of 
selenium (Se) in the kidney but not in the liver (Piotrowski et al., 1977) . 
Since protein synthesis is affected by MeHg and the deprivation of 
protein in rats was shown to cause an increase in -SH concentration in 
the cytoplasm of kidney cells, the levels of mercury and -SH were found 
to be parallel (Clarkson, 1972). Evidence indicates that virtually all 
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the mercury in the kidneys is in the form of methyl and ethyl mercuric 
salts, and intact MeHg radical may persist in animal tissues for many 
weeks after a single exposure (Norseth and Clarkson, 1970). 
Liver is a major site for detoxification of mercury compounds and 
most of the alkyl mercurials are eliminated via the bile and urine. The 
accumulation rate is rapid and besides binding to metallothionein and 
the membrane, conjugation with glutathione (GSH) and cysteine also 
occurs. Enterohepatic circulation of the MeHg has been identified 
(Norseth and Clarkson, 1971). 
The major portion of the circulating blood MeHg in the rat is in 
the erythrocytes, bound mainly to hemoglobin (Chen, et al., 1975), how­
ever in man and the rabbit it is bound mainly to low molecular weight 
substances, more likely GSH rather than hemoglobin within erythrocytes 
(Naganumra and Imura, 1979) . One possible explanation for the distribu­
tional differences of MeHg within the erythrocytes of different species 
is that hemoglobin of the rat contains four -SH groups per molecule where­
as those of rabbit and man have two -SH groups per molecule (Snow, 1962) . 
Although brain accumulates mercury to a lesser degree compared to 
kidney, blood or liver, signs of poisoning appear when the concentration 
in the brain increases more than the concentration of the whole body 
(Magos and Butler, 1976). Estimation of mercury concentration in the 
blood has been used in man for the diagnosis of body burden and brain 
mercury concentration (Swedish Expert Group, 1971). Magos and Butler 
(1976) stated that blood concentration of MeHg might be used with certain 
limitations for the calculation of MeHg concentration in brain; half time 
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value, and final whole body concentration of mercury should be considered 
in such calculations. Butterworth et al. (1978) studied the regional 
distribution of MeHg in the brain following a single intravenous 
administration of CH^^'^^HgCl in rats. They found that it took four days 
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to reach peak accumulation of ' ng by the whole brain and delay in 
accumulation was regionally dependent. They found that the peak levels 
in cerebellum, medulla oblongata and mid-brain, for example, were 
attained sooner than those of hippocampus or cerebral cortex of frontal 
or occipital lobe. Therefore, the accumulation rates for different parts 
of brain are different. Chang ^d Hartmann (1972a) indicated that in rats 
treated with MeHg chloride, different parts of the nervous system 
accumulated mercury in the following order : dorsal root ganglion, 
calcarine cortex of occipital lobe and cerebellum (hichcct). 
Further biochemical analysis of nerve cells revealed that 
the subcellular distribution of mercury in general was mitochondrial 
fraction > microsomal fraction > supernatant fraction •> nuclear fraction. 
Thomas and Smith (1979) found that in brain MeHg formed a persistent 
complex with GSH and this complex accounted for about 30% of the total 
soluble MeHg burden. 
Vitamin E and MethyImercury Interaction 
Welsh (1974) was the first person to show that vitamin E has a 
protective effect against MeHg in fowl. Later, Welsh and Soares 
(1976), Welsh (1976, 1977), Sunde (1976), Chang et al. (1977) 
demonstrated that vitamin E, when given to quail and rats, reduced the 
toxic effects of MeHg in these animals and rendered better growth rates 
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and much longer life spans as conpared to those animals exposed to MeHg 
alone. Kasuya (1975) showed that vitamin E has a direct protective 
effect on the toxic effect of MeHg on nervous tissue cultures. Chang 
et al. (1978) demonstrated the histological evidence of the protective 
effect of vitamin E on nervous tissue of golden hamsters. The precise 
protective mechanism of vitamin E against the toxic effects of MeHg is not 
well established. The ability of this vitamin to prolong survival of 
animals given MeHg may be a significant finding in terms of understanding 
the mechanism of the neurotoxicity of MeHg. A new theory about the 
interactive mechanism of vitamin E and MeHg will be discussed later. 
Selenium and Methylmercury Interaction 
More than a decade ago it was reported that Se counteracts 
acute mercuric chloride toxicity in rats (Parizek and Ostadalova, 1967). 
Later, Ganther et al. (1972) showed that dietary Se delays the effect of 
chronic toxicity of MeHg in rats. since then, this effect has also 
been demonstrated with MeHg in other animals as well as rats (Stoewsand 
et al., 1974; Sell and Horani, 1975; Stillings et al., 1974). 
Se affects the organ distribution of MeHg. It causes increased 
uptake of MeHg in rat brain while exerting a protective effect 
(Prohaska and Ganther, 1977; Magos and Webb, 1977; Ohi et al., 1975; 1976). 
Se supplementation seems to increase mercury concentration in the 
liver, spleen (Potter and Materone, 1974) and brain and decrease its 
concentration in the kidney (Alexander and Norseth, 1979). Because of 
the above mentioned effects. Se is protective against MeHg toxicity. 
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Alexander and Norseth (1979) demonstrated that Se inhibits 
biliary excretion of mercury in rats, and increases enterohepatic 
circulation of MeHg. They also indicated that even a selenite to mercury 
ratio of 1:40 affects the biliary mercury excretion. The increase 
in enterohepatic circulation of mercury by Se was accompanied by a 
decrease in mercury concentration in the kidney. 
The effect of Se on mercury concentration in the brain is dose 
dependent and reaches a maximum at an equimolar selenite to MeHg 
dose ratio (Alexander and Norseth, 1979). 
The theory that Se directly binds to MeHg and alters its toxicity 
can not explain the relatively low level of Se required for the exertion 
of protective action against MeHg. Other mechanisms must be involved 
in mercury/Se interaction. It has been shown that MeHg excreted into 
the bile is mainly bound to GSH (Refsnik and Norseth, 1975). Alexander 
and Norseth (1979) stated that in liver MeHg exists predominantly as 
a MeHg-protein complex, and Se might in seme way alter the transfer of 
MeHg from the protein complex to the GSH or inhibit MeHg and GSH conju­
gation . Therefore, the level of dietary Se plays an important role in 
the excretion of MeHg through the bile. 
Another possible interaction of Se and MeHg is through its effects 
on the activity of seleno enzyme glutathione peroxidase (GSH-Px). Se 
may preferentially bind to GSH-Px and protect against MeHg toxicosis 
(details to be discussed later). Diplock (1976) indicated that selenite 
was methylated through S-adenosylmethionine (SAM) and was excreted in 
urine as '''se- (CH^) ^ and exhaled as '^Se-(CH3)2- Therefore, Se metabolism 
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produces two or three S-adenosyl-homocysteines; subsequently two or three 
homocysteines with free -SH groups separated from S-adenosylcysteine, 
which can bind MeHg. Magos and Sell also proposed (personal 
communication^) that the methyl group might bind to -SH group and 
form mercurymethionine which is transported to the brain and is 
incorporated into protein. This theory might explain the increase 
in mercury concentration of brain with Se supplementation. Also, it is 
reasonable to assume that the presence of Se prevents MeHg from binding 
to GSH and promotes mercury-methionine formation. 
Mechanism of Action 
It is often proposed that the toxic effect of mercury is due to its 
binding to sulfur ligands in proteins. This theory, however, has not 
been definitely proven. Passow et al. (1961) indicated that mercury 
ions probably caused damage to the membrane structure by forming cross 
linkage with the protein moiety of the cell membrane resulting in the 
formation of an abnormal structure which in tern causes the impairment 
of membrane functions as well as increase in permeability. Kasuya (1972) 
postulated that organic mercury compounds bind to the cellular membranes 
and result in a degeneration of the membrane structure. These presump­
tions of mechansim of toxic action are based on the findings that some 
of the phospholipids such as sphingomyelin or phosphatidyl-L-serine 
show an inhibitory effect on the toxic effect of ethylmercuric chloride. 
a 
Dr. Jerry Sell, Department of Animal Science, Iowa State Uni­
versity, Ames, Iowa. 
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Also a direct protective effect of vitamin E as a membrane stabi­
lizer against the toxic effect of MeHg on nervous tissue cells has been 
shown (El-Bergrami et al., 1976; Kasuya, 1975; Welsh, 1974; Lucy, 1972; 
Brown and Pollock, 1972; Kurokama et al., 1970; Porta et al, 1968). 
Another mechanism that has been considered is that some of the 
toxic effects of mercury result from forming complexes with biologically 
active Se, such as in glutathione peroxidase (GSH-Px) (Hoekstra, 1975; 
Ganther, 1975). The evidence for this mechanism is derived from the find­
ings of Forseth et al. (1974) and Welsh (1974) who showed that MeHg may 
induce signs of Se deficiency. Subacute doses of MeHg also caused a slight 
reduction in GSH-Px activity in rat brain (Prohaska and Ganther, 1977). 
There is a characteristic lag period of at least one week before 
the manifestation of poisoning with alkylmercury compounds (Clarkson, 
1972); this lag period is present regardless of whether a single 
dose or continuous doses are involved. No mechanism for this lag period 
has been established. 
Recently Ganther (1978) proposed a new theory of mechanism of action 
of MeHg toxicity. In this theory, the possible role of free radicals in 
MeHg toxicity was described. Basically, the theory proposed that the CNS 
damages exerted by MeHg may involve free methyl radical (:CH^) formation 
by the breakdown of MeHg and may not necessarily involve the intact 
molecule. This radical in turn will initiate the breakdown of MeHg. 
Presuming that free radicals are involved in the breakdown of the MeHg, 
and considering the MeHg physical properties, it might be taken up by 
the membrane in close proximity to lipids. It would then initiate 
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peroxidation of various lipid constituents as a result of its chemical 
tendency to undergo homolytic fission, perhaps initiated by radicals 
produced by oxygen dependent metabolic reactions. The onset of CNS 
damage would be preceded by a lag phase, during which the various systems 
defending against lipid peroxidation would be overcome, followed by a 
rapid and progressive degeneration of tissue (Ganther, 1978). 
The theory of Ganther (1978) also explains the protective mechanisms 
of Se and vitamin E, as well as other antioxidants, against MeHg toxicity. 
Se as a component of GSH-Px which decomposes hydrogen peroxide and hydro­
peroxides would slow down the process of MeHg breakdown and methyl 
radical production. Vitamin E would modify MeHg metabolism by acting 
as a radical scavenger. It might be more efficient than other anti­
oxidants because of its location in the membrane, and stablizing 
the membrane by interacting with unsaturated fatty acid chains. 
Although there is no conclusive evidence in support of this 
theory at the present time, it seems to be the most logical inter­
pretation of the mechanism of MeHg toxicity, and the protective effects 
of vitamin E and Se. 
Toxicology of Atrazine 
One of the most commonly used herbicides and plant growth regulating 
compounds of the aminotriazine series is atrazine (2-chloro-4-ethylamino-
6-isopropylamino-l,3,5-triazine), (Figure 1), (Dalgaard-Mikke1sen and 
Poulsen, 1962). 
Simazine, propazine, Trietrazine, Ipazine, Simetone, Prometone and 
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Figure 1. Atrazine (2-chloro-4-ethylaiiiino-6-isopropylamino-l,3,5 
Atratone are the common names of triazine compounds with slight dif­
ferences on the side chains of the triazine structure-
Atrazine and other similar compounds are mostly water-soluble and 
persist in soil (Dalgaard-Mikkelsen and Poulsen, 1962); therefore, 
residues of atrazine in soil may enter human and animal food. Its 
use with resistant crops (Shimabukuro et al., 1971) may also result 
in the accumulation of a residue in crops used for human and animal 
consumption. 
Corn and sorghum metabolize atrazine to 2-hydroxyatrazine and 
conjugates with GSH and cysteine. The major detoxification of atrazine 
in corn and other plants is found to be through conjugation with GSH 
(Shimabukuro et al., 1970). The enzyme that catalyzes the reaction of 
atrazine with GSH in plants, GSH S-aryltransferase, has been partially 
triazine) 
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purified (Chasseaud, 1973). The activity of the enzyme in the plant 
determines its susceptibility to the herbicide atrazine (Shimabukuro 
et al., 1971). 
Atrazine is rapidly metabolized after oral ingestion by the rat. 
Bakke et al. (1972) found that in the rat 55.5% of the metabolites were 
excreted in urine and 20.3% in feces. They identified and characterized 
atrazine metabolites. Dealkylation was also found to be a major detoxi-
cation mechanism in rat, rabbit, goat, sheep, and chicken (Foster and Khan, 
1976) . Rat liver has been shown to have glutathione-S-transferase enzyme, 
with a pH optimum of about pH 8, which catalyzes the conjugation of GSH 
with atrazine (Crayford and Hutson, 1972). Hutson et al. (1970) speculated 
that glutathione-S-aryltransferase could be involved in the metabolism of 
2-chloro-triazines. The halogen group of the atrazine molecule was replaced 
by GSH and the conjugated product was excreted in the form of mercapturic 
acid. Crayford and Hutson (1972) indicated that the enzyme is located in 
hepatic cytosol. Johnson et al. (1972) indicated that this herbicide when 
applied to forage at the maximal recommended use rate, did not cause 
any adverse or toxicological effects in cattle or sheep. 
Although atrazine is vastly used in agriculture, the residue alone 
in the food and environment is far less than apparently needed to cause 
any serious problem. It is possible that its toxicity would be 
synergized by other toxicants which deplete GSH in the body. Therefore, 
it can be employed in experiments as a GSH depleting agent. 
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Dietary Methionine and Glutathione 
Methionine (Met) is an essential sulfur amino acid which is 
abundant in animal products such as meat, poultry, fish, milk, cheese 
and eggs (Mitchell et al., 1976). Met has several metabolic functions. 
As shown in Figure 2 (Mudd and Poole, 1975), the major functions of 
Met are its utilization in protein synthesis and conversion to SAM, 
cystathionine and cysteine. 
The amount of Met required may be somewhat reduced if cysteine, a 
sulfur-containing nonessential amino acid, is supplied in the diet in 
adequate amounts (Mitchell et al., 1976). Addition of up to 1% DL-
methionine in the diet was shown to improve growth rate and protein 
utilization of rats fed an 8% casein diet, but with the addition of 1.5-
3% growth was inhibited and protein utilization was impaired (Harper 
et al., 1970) . 
Met is one of the most toxic amino acids (Hathcock, 1976). Amounts 
exceeding 2% of the diet will cause severe growth depression. Harper 
et al. (1970) stated that the inhibitory effects of Met on growth depend 
on type of protein in the diet. The addition of 2% Met to a diet contain­
ing 10% soy bean protein caused a 40% increase in growth, while the 
addition of 2% Met to diets containing 18-24% casein caused depression 
of growth rate to 50-80% of control value. 
The major regulatory point in the metabolism of Met is the 
distribution of available Met between protein synthesis and SAM 
formation. The second control point is practically irreversible con­
version to homocysteine, from which cystathionine and cysteine form by a 
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transsulfuration pathway (Finkelstein et al., 1980). The activity of 
several of the enzymes involved in Met metabolism may be modified by 
changes in the concentration of sulfur containing amino acids in body 
fluids and by the action of hormones (Harper et al., 1970). 
Met can be a precursor of GSH. GSH is an endogenous protective 
tripeptide (Figure 3) which is synthesized in cytosol by two ATP-de-
pendent steps and utilizes glutamate, cysteine and glycine (Figure 4). 
Cysteine is an immediate precursor of tissue GSH, whereas Met is a more 
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distal precursor of GSH and it operates through a transsulfuration 
pathway. 
Isolated hepatocytes have been shown to be capable of biosyn­
thesis of GSH from exogenous methionine through the cystathionine path­
way (Thor et al., 1979; Krebs et al., 1978). Campbell et al. (1978) and 
Poirier et al. (1977) showed that a methionine deficiency with other 
lipotrope deficiencies did not alter the hepatic level of GSH, while it 
caused a decrease in SAM in male rat liver. 
The capability of isolated kidney cells in catalyzing this pathway is 
less than that of hepatocytes, and the cysteine generated by the cysta­
thionine pathway in kidney cells is not sufficient to support biosynthe­
sis of GSH (Ormestead et al., 1980). 
GSH is the major nonprotein thiol compound found in all types of 
living cells. It occurs in a dynamic state, and there is an interorgan 
cycle of glutathione metabolism. Anderson and Meister (1980) indicated 
that glutathione is translocated to plasma in the form of GSH which 
constitutes the major source of plasma thiol. Griffith and Meister 
(1979) stated that substantial amounts of GSH are translocated from 
liver and probably from other tissues in the blood plasma. The thiol 
group (-SH) of GSH is the most chemically important active group in its 
biological and biochemical function. However, in the y-glutamyl cycle 
for amino acid transport across the plasma membrane the -SH group is 
not involved. 
GSH has a potent oxidation-reduction capability and it plays a 
protective role against hydroperoxides and prevents the formation of the 
hydroxy radicals ('OH) (Sunds and Hoekstra, 1980) by the formation of 
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glutathione disulfide (GSSG). The enzymes involved in the oxidation and 
reduction of GSH are glutathione peroxidase (GSH-Px) and glutathione 
reductase (GSH-Rd), respectively. 
GSH plays an important role as an intracellular reducing agent and 
protects the -SH groups of proteins from oxidation. It also regulates 
mitosis, cytoskeletal structure, intermediary metabolism of enzyme 
activity, and also regulates the synthesis of macromolecules (Suojanen et 
al., 1980). GSH serves as a coenzyme for several enzymes (Metzler,1977). 
Conjugation of compounds with GSH is either direct or following acti­
vation by a cytochrome P-450 dependent oxidation. Conjugation may occur 
spontaneously or may be catalyzed by glutathione S-transferase (GSH S-
trans) (Moldeus et al., 1978). The conjugated compound then can undergo 
mercapturic acid biosynthesis as shown in Figure 5 (Chasseaud, 1976). 
Sulfur amino acids are also important in other detoxication 
mechanisms such as mixed-function oxidase (MFO) enzymes which metabolize 
a variety of substances. Edes et al. (1979) has shown that Met and 
cysteine deficiency causes a reduction of intestinal and hepatic MFO 
enzyme activity. Therefore, dietary sulfur amino acids, in addition to 
their important role in growth, protein synthesis and other biological 
functions, play an important role in the metabolic fate of numerous toxic 
compounds in human and animals. 
Functions of Glutathione Peroxidase and Reductase 
A "glutathione peroxidase system" consists of GSH-Px, GSH-Rd, and 
glucose-6-phosphate dehydrogenase (G6PD) which function as a metabolic 
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unit in the reduction of peroxides (Reddy and Tappel, 1974). GSH-Px 
utilizes GSH oxidation capability and appears to function in animals 
as a protective enzyme that guards against peroxidative damage. The 
enzyme was discovered by Mills (1957) . It was shown to protect the 
erythrocyte against hemoglobin oxidation and hemolysis (McCoy and 
Weswing, 1959). It has also been shown that there is a GSH-Px which 
is a selenoenzyme. Flohe et al. (1973), Nakamura et al. (1974), and 
Awasthi et al. (1975) demonstrated that GSH-Px contained 4 gram-atoms 
of Se bound to cysteine, and it is present as selenocysteine (Cone et 
al., 1976, 1977; Frostrom et al., 1978; Zakowski, 1978). Se is essen­
tial for the enzymatic activity of GSH-Px, and it goes through an oxi­
dation reduction cycle during catalysis (Flohe et al., 1973). 
Animals maintained on Se deficient diets show a rapid decline of 
tissue GSH-Px activity (Cantor et al., 1975). Selenite, selenometh­
ionine, and selenocysteine generally have good biopotency for the syn­
thesis of GSH-Px (Pierce and Tappel, 1977; Hawkes et al., 1979). How­
ever, it has been reported that selenate does not have such biopotency, 
and it is not the form used for GSH-Px biosynthesis (Germaine and 
Arneson, 1977). Hydrogen peroxide as well as organic hydroperoxides 
are substrates for GSH-Px (Rotruck et al., 1973; Little and O'Brien, 
1868a, 1968b; Christophersen, 1968, 1969). Activated oxygen and free 
radicals, as products of normal cellular reactions or as products of 
the metabolism of toxic substances, may attack cellular components and 
cause hydroperoxide formation. GSH-Px together with superoxide dis-
mutase may prevent the hydroxy radical (-OH) formation by reducing the 
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concentration of superoxide and hydrogen peroxide so they cannot 
react with one another (Sunde and Hoekstra, 1980). 
It is known that vitamin E scavenges free radicals and possibly 
quenches activated oxygen. Since vitamin E is lipid soluble, it reacts 
on the membrane and is a lipid antioxidant (Tappel, 1962), whereas GSH-Px 
is located in the cytosol and mitochondria and guards cytoplasm against 
peroxidative damage. Sunde and Hoekstra (1980) stated that although 
lipid hydroperoxides are excellent substrates for GSH-Px, this soluble 
enzyme does not reduce lipid hydroperoxides to the corresponding alcohols 
in vitro. Instead GSH-Px prevents the peroxidation by destroying hydro­
gen peroxide, and thus preventing the formation of hydroxy radicals. 
When autooxidized lipids were fed to rats which were receiving diets 
low in Se, hepatic GSH-Px activity was shown to be increased (Reddy and 
Tappel, 1974). 
The effects of vitamin E on the activity of GSH-Px of liver are 
controversial. Fukezawa and Tokumura (1976) have shown that hepatic 
GSH-Px activity decreased in mice with vitamin E deficiency, whereas 
Torstler et al. (1979) demonstrated that the activity of GSH-Px of 
liver increased in rats fed low vitamin E and Se diet. Recently, 
Lawrence and Burk (1976) reported an increase of GSH-S-transferase 
activities in the liver of Se deficient rats which had low levels of GSH-
Px. They also showed that there are at least two GSH-Px activities in 
rat liver. One is Se-dependent GSH-Px which utilized hydrogen peroxide 
as well as many organic hydroperoxides as substrates, and the other is a 
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Se-independent GSH-Px which has been shown to have the activity of sev­
eral GSH-S-transferases. The Se-independent enzyme cannot use hydrogen 
peroxide as a substrate, but protects against lipid peroxidation in the 
NADPH-microsomal lipid peroxidation system (Burk et al., 1980). In some 
tissues, the peroxidase activity from the transferase is much higher 
than that of GSH-Px and it has been shown that guinea pig liver has no 
detectable Se-dependent GSH-Px activity (Prohaska, 1980). Therefore, 
the GSH-S-transferase also may be important in the protection of cells 
against peroxidation. 
It is also postulated that GSH-Px may have a specific function in 
the metabolism of prostaglandin hydroperoxide (Nugteren and Hazelhof, 
1973; Hazelhof and Nugteren, 1978), and of arachidonic acid in platelets 
(Bryant and Bailey, 1980; Ohki et al., 1979). 
Since there is an interaction between Se and mercury, it is possible 
that the enzyme activity of GSH-Px is affected by MeHg. Subacute doses 
of MeHg have been shown to cause a slight reduction in GSH-Px activity 
of rat brain (Prohaska and Ganther, 1977). Hirota et al. (1980), 
investigated the effect of MeHg on the activity of GSH-Px in 100,000 g 
supernatant of rat liver homogenate ^  vitro. They found marked 
inhibition of enzyme activity with concentrations of MeHg between 
5 X 10 M and 5 x 10 M, but activity was hardly inhibited at 
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concentrations less than 5 x 10 M MeHg. They also showed that 
inhibition was complete at concentrations greater than 5 x 10~^M MeHg. 
GSH-Rd is a flavoenzyme which catalyzes the pyridine nucleotide-
dependent reduction of GSSG to reduced glutathione (GSH) and maintains 
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a high ratio of GSH/GSSG in cells. It is also a radical scavenger, and 
may regenerate other antioxidants such as a-tocopherol and serves to 
activate enzymes through disulfide exchange (Pryor, 1976). The activity 
of this enzyme is quite high in liver; thus, liver has a high capability 
to cope with conditions which bring about rapid oxidation of GSH 
(Moron et al., 1979). Kum-Tatt et al. (1975) indicated from their 
findings that GSSG is catalyzed by one type of GSH-Rd enzyme which is 
nonspecific for NADH and NADPKfJ 
In the erythrocyte, GSH-Px, GSH-Rd and G6PD function as a single 
unit for peroxide reduction, and only the hexose mono-phosphate shunt 
produces NADPH for this unit but in the liver the G6PD serves an im­
portant role in regeneration of NADPH for fatty acid synthesis and there 
is a linear relationship between GSH-Rd and G6PD in mice. Thus, the 
maintenance of GSH-Rd need not be linked solely to peroxide reduction 
(Torstler et al., 1979). 
Webb (1953) stated that inorganic mercury can inhibit GSH-Rd 
activity. Pekkanen and Sandholm (1972) found that rat liver GSH-Rd 
was not affected by MeHg, but brain GSH-Rd activity was decreased by MeHg 
administration. In addition, Mykkanen and Ganther (1974) found that 
blood GSH-Rd activity in rats and quail fed as high as 30 ppm MeHg were 
not affected- Furthermore they showed that there was a great difference 
between the effect of inorganic and organic mercury on the activity of 
rat erythrocyte GSH-Rd. A concentration of 1.6 ppm mercury as mercuric 
nitrate added to blood vitro, resulted in 30-40% of decrease in activity 
of GSH-Rd, whereas about 200 ppm mercury as MeHg was necessary for the 
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same inhibition- They speculated that differences between organic and 
inorganic mercury in the inhibition of GSH-Rd activity might be due to 
structural differences which result in a preference of GSH-Rd for 
binding mercuric mercury or in a preference of hemoglobin in the hemol-
sate for binding MeHg. 
It is known that GSH conjugates MeHg and atrazine as part of the 
detoxication mechanisms of liver. Since availability of GSH as a sub­
strate for GSH-Px will be decreased by exposure to MeHg and atrazine, 
it is very likely that the activity of GSH-Px and interrelated enzymes 
like GSH-Rd, and glutathione-S-transferases also will be altered by 
exposure to these toxicants. 
Functions of Glutathione-S-transferases 
Conjugation with GSH is one of the biotransformation processes 
that generally results in less toxic products. The glutathione-S-
transf erases (GSH-S-trans) are a group of soluble enzymes that catalyze 
the conjugation of GSH with a wide range of electrophilic agents (Arias 
and Jakoby, 1976) . Several GSH-S-transferases have been identified 
in the rat liver cytoplasmic fraction. They are transferases AA, A, 
B, C, D, and E, and they have been shown to have very broad and 
overlapping substrate specificities (Habig et al., 1974; Keen et al., 
1976; Jakoby et al., 1976). Multiple forms of these enzymes were also 
found in liver of the monkey (Asaoka et al., 1977) and man as well 
(Kamisaka et al., 1975). 
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GSH-S-trans enzymes constitute about 10% of the total extractable 
soluble protein from rat liver (Jakoby, 1978). GSH-S-trans B has also 
been identified as the cytoplasmic electrophile binding protein ligand 
in liver (Habig et al., 1974). 
There is evidence that these enzymes are present in the kidney 
(Kaplomitz et al., 1976), small intestine (Pinkus et al:, 1977), lung 
(Guthenberg and Mannervik, 1979), and steroidogenic organs (Bend et al., 
1977). Several studies, usually on the rodents, have shown that,'GSH-S-trans 
activities towards a range of electrophiles are generally highest in 
liver and steroidogenic organs such as adrenals, ovary and testis (Kraus 
and Kolft, 1980; Chasseaud, 1979; Datta et al., 1973). Kraus and 
Kolft. (1980) found that activities of these enzymes in the heart, 
brain, spleen and lung were relatively low or nil for most substrates. 
Although the presence of these enzymes was determined in the other 
organs, the present data do not permit one to evaluate the role of 
different tissues in catalyzing the conjugation of GSH with electro-
philic xenobiotics. Kraus and Kolft (1980) also speculated that the 
presence of GSH-S-trans in the other organs might protect nucleophilic 
components of tissue from denaturation by electrophilic reactants, or 
they might be needed for transport of protein. Transferase activities 
in the soluble fraction of liver of mice were shown to have significant 
differences between the male and female (Hayakawa et al., 1974). It was 
shown that male mice had twice as much activity as female mice with 
naphthalene-1,2-oxide as the substrate; however, when styrene oxide was 
used as the substrate, no significant differences between the sexes 
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were observed. 
The enzyme activities also appear to be age dependent (Mukhtar et 
al., 1979). Hayakawa (1977) stated that livers from 17 to 18 day rat 
embryos showed almost no activity; however, the activity appeared and 
sharply increased at about three weeks of age and reached a maximum 
at about six weeks of age. 
GSH-S-trans has other detoxification functions in addition to GSH 
conjugation. One is the binding of a large number of xenobiotics as 
well as a bilirubin, until they are converted to less toxic compounds 
(Wolkoff et al., 1978). GSH-S-trans also has been claimed to have 
activity as a scavenger protein (Smith et al., 1977). In addition, the 
intermediate reactive products of drugs biotransformation which are 
thought to play an important role in carcinogenesis, mainly bind 
covalently to a ligand which is identical to GSH-S-trans B. 
The hepatic cytoplasmic treatments such as phénobarbital, DDT, 
methylcholanthrene, trans-stilbene oxide and rifampcin, as well as fast­
ing and some other metabolic disturbances, induce these enzymes (Younes 
et al., 1980; Friedberg et al., 1979; Down and Chasseaud, 1979). 
Inducibility of GSH-S-transferases in hepatocytes of two species of non-
human primates is lower than in the rodents (Down and Chasseaud, 1979). 
Microsomal GSH-S-trans activity in rat liver was also reported by 
Booth et al. (1961). Such activity was reported also in the microsomes 
and mitochondria of rat liver (Kraus and Gross, 1979) and in mouse liver 
(Glatt and Oesch, 1977). 
The catalytic characteristics of microsomal GSH-S-transferases are 
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quite different from cytoplasmic ones. The enzyme cannot be removed from 
the membrane, but the enzyme is at least partially exposed on the cyto­
plasmic surface of endoplasmic reticulum (Morgenstern et al., 1980). 
Three microsomal GSH-S-transferases were identified in the rat liver by 
Friedberg et al. (1979), and they found that the pattern of GSH-S-
transferases in the microsomal fraction is similar to that in the 
cytoplasm. However, the specific activity of cytoplasmic enzymes was 
shown to be increased by inducer agents, but microsomal enzyme activity 
was not affected (Friedberg et al., 1979; Morgenstern et al., 1979). 
Morgenstern et al. (1979) proposed that the -SH group is involved in 
the activation of microsomal GSK-S-transferase activity and presented 
evidence that activation results from attack on the microsomal 
sulfhydryl group(s). Membrane bound GSH-S-transferase may be advanta­
geous in the inactivation of reactive metabolites formed within the 
microsomal membrane, which are lipophilic and therefore remain within the 
membrane rather than diffuse into the cytoplasm (Friedberg et al., 1979). 
Prostaglandins 
The prostaglandins (PGs) are derivatives of essential fatty acids. 
Each compound has a five membered ring structure and two side chains. 
They seem to be synthesized by all mammalian cells with the possible 
exception the mature red blood cells. The PGs are realized to be involved 
in the fundamental responses of cells and organs (Horrobin, 1978). In 
PG synthesis, endoperoxide formation is the critical point. Regulation 
of PG synthesis may depend on regulation of essential fatty acid 
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metabolism (Van Drop, 1971; Ramwell et al., 1977), regulation of lipase 
activity (Sameulsson, 1969; Ramwell et al., 1977; Flower, 1977), 
cofactors, and steroid hormones (Horrobin, 1978). 
Some compounds may inhibit or stimulate biosynthesis of PCs. 
From the view point of my interest, it was documented that GSH enhances 
PGEg production at the e:gense of the other PCs. Horrobin (1978) 
stated that omission of GSH tends to increase production of other 
PGs, including PGF- The omission of GSH did not alter oxygen consumption 
although PGE^ formation was reduced. Ho et al- (1976) found that there 
was no effect of GSH on thromboxane (TXB^) production while Tai and 
Yuan (1977) reported some stimulation of TXB^ synthesis. 
Since oxidation and reduction play a critical role in the formation 
of PGs, agents which modify redox states may modify PG synthesis (Nugteren 
and Hazelhof, 1973). Antioxidants such as a-tocopherol inhibited PG 
synthesis (Nugteren, 1970; Lands and Rome, 1976) ; however, at low 
concentrations, synthesis might be enhanced, especially the PGEs. 
Morse et al. (1977) reported a stimulatory effect of hydrogen 
peroxide on PG synthesis in various tissues. They stated that H^Og or 
some product derived frcm this molecule might act in concert with or on 
the prostaglandin endoperoxide forming cyclooxygenase or on some 
substrate formed as a consequence of activity of this enzyme. They 
suggested that and organic peroxides derived from it serve as 
donors of some electronically activated species of oxygen (such as 
hydroperoxy free radical HOO., or the peroxy radical .00.) that is 
uniquely reactive and suitable as substrate for the cyclooxygenase-
33 
catalyzed addition of oxygen. 
Horrobin et al. (1978) suggested a decrease in PGE^ synthesis due 
to excess methionine. They stated that Met gives rise to taurine which 
decreases PGE^ synthesis via inhibition of the prolactin effect on PGE^ 
production in brain tissue. Both PGE^ and were shown to be 
involved in anxiety and depression (Horrobïn, 1978). 
Although there are no reports indicating the effects of MeHg and 
atrazine on PG synthesis, consequent to these points it is more 
likely that PG synthesis could be altered indirectly by these 
toxicants possibly through an effect on the GSH and/or GSH—Px systems. 
Significance of Behavioral Studies in 
Toxicant and Nutrient Interactions 
Although the deleterious effects of many substances have been 
known for many years, their effects on behavior have not been well 
documented. Chronic low dose exposure of man and animal to toxicants 
might produce no observable pathological or biochemical changes, 
whereas behavioral impairment might be present. Behavioral measures 
might provide more sensitive indices of the consequences of exposure 
to the environmental toxicants than clinical measures. 
The nervous system serves to maintain homeostasis under certain 
input/output conditions. When output is generated which involves the 
motor system a measurable behavior occurs (Reiter, 1978). Behavioral 
impairment might not necessarily result from the effect on the 
particular function or structure of nervous system. Reiter (1978) 
stated that a chemical might act to disrupt the input/output relation­
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ships either by directly affecting some levels of neuronal organization 
or by interacting with other organ systems, thus affecting nervous 
system function indirectly. 
The nervous system is not often identified as the primary site of 
damage by MeHg compounds. Behavioral and neurological symptoms are 
virtually the only ones detectable in very low chronic exposure. Few 
overt neurological signs appear before advanced stages of toxicity are 
manifested (Hughes et al., 1975). A wide variety of behavioral tests 
such as open field behavior, active avoidance, learning ability, 
operant reinforcement, and discrimination behavior have been employed 
with animals to assess MeHg effects on motor and sensory systems. 
Suzuki and Miama (1971) demonstrated in mice that when mercury 
was accumulated slowly, symptoms were more associated with lower brain 
concentrations than when accumulation was rapid. Lown et al. (1977) 
indicated that the route of administration of 10 mg mercury as MeHg 
per kg of body weight is important in behavioral impairment in rat. They 
found that ambulation and rearing of rats were depressed in open field 
behavior tests when MeHg was administrated intraperitoneally whereas 
other routes of administration of MeHg did not affect the open field 
behavior of rats. They also found that behavioral alterations were not 
directly related to brain mercury level following acute administration 
of MeHg by different routes, but liver and kidney mercury levels were 
significant predictors of behavior. Reduced locomotion and re siring 
in the open field in rats exposed to high doses of MeHg were observed 
by Post et al. (1973). They found that rats required significantly 
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more trials to leam a T-maze after oral administration of MeHg in a 
single dose of 20 mg mercury per kg body weight. 
Zenick- (1974) showed that the ability of rats to swim through 
a water maze was impaired following an indeterminate dose of MeHg 
given at early stages of development. Hughes et al. (1975) demonstrated 
that in rats exposed to small amounts of MeHg at age 28-42 days, the 
ability to learn an active avoidance response as adults was 
impaired. Evans et al. (1975) used visual form and brightness discrimi­
nation to study chronic MeHg intoxication in monkeys and found significant 
alterations. 
Since MeHg accumulates in brain, it may cause an alteration in 
the neurotransmitter synthesis. Acetylcholine (Ach) is one of the 
several transmitters which is synthesized in the neurons. Kobayashi 
et al. (1980) postulated that MeHg poisoning might reduce Ach concen­
tration and turnover rate in brain of mice. PGEg and 11-thiol-ll-deoxy 
PGEg were shown to possess an anticholinergic effect (Bloss and Singer, 
1978). Since PGs effects on brain function might be dependent on 
modulation of transmitters actions (Horrobin, 1978), it is possible 
that changes in PG synthesis by MeHg through alteration in the GSH-Px 
system cause a change in neurotransmitter concentration or turnover 
rate which in turn alters the behavior of the animal. Possibly excess 
Met exerts its neurological effect through alteration in PG synthesis 
(Horrobin et al., 1978). 
As shown by the studies cited above it is clear that behavioral 
alteration in animals by toxicant and nutrient interaction should be 
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considered closely and the mechanism of action and biochemical pathways 
which are involved in certain behavioral responses should be in­
vestigated. 
Summary and Conclusions 
Exposure to methylmercury and atrazine has deleterious effects on 
the physiological homeostasis of the human and animal body. Methyl-
mercury and atrazine are both introduced into the environment and food 
chain through industrial and agricultural activities (Rowland et al-, 
1977; Shimabukuro et al., 1971). Accidental consumption of agricultural 
commodities containing some amount of these toxicants has resulted in 
some tragic human.episodes (Bakir et al., 1973; Skerfving and Copple-
stone, 1976). 
The neurotoxicity of methylmercury is well-documented (Thomas and 
Smith, 1979; Chang and Hartmann, 1972a, 1972b; Skerfving and Vostal, 
1972). The detoxification mechanism for methylmercury and atrazine have 
been studied by Norseth and Clarkson (1970, 1971), and by Crayford and 
Hutson (1972), respectively. Both toxicants are shown to be conjugated 
with GSH and excreted partially as mercapturic acids in urine. The con­
jugation is catalyzed by GSH-S-trans, of which several have been iden­
tified (Habig et al-, 1974; Keen et al-, 1976; Jakoby et al., 1976)-
GSH is the major nonprotein thiol compound in all types of living 
cells- It also plays a protective role against hydroproxides and hydroxy 
radicals (Sunde and Hoekstra, 1980). Since both toxicants are conjugated 
with GSH, they might have the capability of depleting GSH of human and 
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animal bodies exposed to these toxicants for long periods of time. 
Therefore, GSH biosynthesis and GSH-Px, and GSH-Rd activities possibly 
will be altered in this condition. 
There are significant numbers of studies on the role of Se and 
vitamin E in relation to mercury toxicity (Welsh, 1976, 1977; Kasuya, 
1975; Ganther, 1978; Alexander and Norseth, 1979). Since there is an 
interaction between se and mercury, the activity of selenoenzyme GSH-Px 
may be altered through such interactions. 
Synthesis of PCs might also be affected by both toxicants indirectly, 
probably through changes in GSH level or GSH-Px activity in the tissues 
(Horrobin, 1978; Tai and Yuan, 1977). Increase of endogenous hydrogen 
peroxide may also elevate PG synthesis (Morse et al., 1977). The role 
of antioxidant a-tocopherol and methionine on PG synthesis has also 
been studied (Nugteren, 1970; Lands and Rome, 1976; Horrobin et al., 
1978). 
The behavior of animals has been shown to be changed when exposed to 
toxicants. Several investigators have studied the behavioral effects 
of acute and chronic exposure to methylmercury (Suzuki and Miama, 
1971; Lown et al., 1977; Post et al., 1973; Zenick, 1974; Hughes et al., 
1975). Ths behavioral effects of atrazine alone or in combination with 
methylmercury in man and animals, however, have not been studied. 
An hypothesis can be made based on the present information indicating 
that synergistic GSH depletion is possible by one exposure to methyl­
mercury and atrazine. Since methionine is convertible to cysteine, 
which in turn is a substrate for GSH synthesis, an experiment with 
administration of low, normal, and excess dietary methionine to 
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cinimals receiving methylmercury and atrazine subacutely, will provide 
valuable information on the alleviation of methylmercury and atrazine 
toxic effects. If so, such a diet modification would be appropriate 
for the human population which is more likely to be exposed to both 
toxicants or similar toxicants with similar biochemical actions. 
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MATERIALS AND METHODS 
Animals and Treatments 
Randomly bred weanling male Wistar rats from the stock colony of 
the Department of Food and Nutrition at Iowa State University were used. 
The study was conducted in two replicates with 72 rats per replicate for 
a total of 144 rats. Each replicate included 18 treatments with four rats 
per treatment for a total of eight rats per treatment in the complete study. 
Rats were randomly assigned to each treatment and were housed 
individually in hanging type stainless steel wire mesh rat cages (40 x 
24 X 20 cm). Animals were maintained at 22° with 12 hours of light and 
12 hours of darkness per day. Diets and distilled water were provided 
ad libitum and changed twice weekly unless otherwise specified. Rats 
were treated in the two following phases with diets and toxicants : 
Pre-exposure Phase (26-32 days) In this phase, rats were 
adjusted to the new environment and received basal diet with adequate 
methionine for 20-26 days after which they were fed the experimental 
diets (without atrazine) until the beginning of the next phase. On the 
fifth day of this phase, water was removed for 12-14 hours during the 
dark period of the day. Water deprivation was used to motivate rats 
to respond to the light stimuli in testing chambers. Animal health and 
weight gains were recorded every three days. 
Exposure phage In this phase, methylmercury hydroxide and/or 
atrazine were fed to the appropriate groups of rats (see page 45). Water 
was removed for 12-14 hours during the dark period of the day. Urine was 
collected one and three weeks after starting toxicant treatment and also 
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a day prior to sacrificing the rats at the end of each phase. Rats were 
closely observed for their general health appearances and neurological 
effects of methylmercury hydroxide toxicity. Onset of hind limb paral­
ysis and gait alteration was recorded for rats receiving methylmercury 
hydroxide at higher dose levels. Weight was measured every other day 
and two choice form discrimination tests were conducted every day of this 
phase. 
Diets 
The composition of the basal diet is shown in Table 1. Isolated 
soy protein was used because it is deficient in the sulfur amino acids. L-
methionine was used to adjust the sulfur amino acid content of diets. The 
methionine adequate and methionine excess diets contained 0.24% and 0.48% 
L-methionine, respectively. The basal diet and the diets with two 
levels of added methionine contained methionine and cysteine concentra­
tions shown in Table 2. The 1:1 methionine to cysteine ratio was just at 
the limit of the useful cysteine replacement for methionine (National 
Research Council, National Academy of Sciences, 1978). 
Selenium and vitamin E were added to the diet at a concentration of 
0.1 mg and 30IU per kg of diet respectively. These levels of selenium and 
vitamin E were chosen to provide adequate nutrition under normal conditions; 
each level added was equal to 100% of the rat's requirements for selenium 
and vitamin E (National Research Council, National Academy of Sciences, 
1978). 
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Table 1. Composition of basal diet^ 
Ingredient % weight 
Isolated soy protein^ 15.2 
Corn starch^ 30.5 
d 
Sucrose 31.0 
Cellulose® 8.8 
Lard^ 5.0 
Corn oil^ 3.5 
Salt mix^ 5.0 
Vitamin mix^ 1.0 
Total 100.0 
^The basal diet contains 60% of NRC rat requirement for methionine/ 
cystine. 
^Supro 660, Ralston Purina Company, St. Louis, MO. 
^Teklad, Madison, WI. 
^lowa State University, Food Service. 
®Teklad, Madison, WI. 
^Mazola brand from Iowa State University Food Service. 
^William and Briggs salt mixture (modified), Tekled, Madison, WI, 
with Na^SeO^ added to provide 0.1 mg Se/kg diet. 
^Amount in 100 kg diet: vitamin A acetate, 800,000 lU; vitamin D 
cholecalciferol, 200,000 lU; vitamin K menadion, 10 mg; vitamin 
B , 25 mg; biotin, 10 mg; folic acid, 500 mg; thiamin HCl, 1 g; 
paraamino benzoic acid, 40 g; Ca-pantothenate, 2 g; niacin, 5 g; 
pyridoxin, 5 g; riboflavin, 1 g; cholin citrate, 120 g; inositol, 
40 g; corn starch to 1 kg; vitamin E DL-a-tocopherol 30 lU/kg diet 
was added to the fat prior to mixing with the other ingredients. 
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Toxicants 
Atrazine was mixed uniformly with the appropriate diets at a 
concentration of 500 mg/kg as powdered technical grade atrazine (97.2%). 
Atrazine was provided by the Ciba-Geigy Corporation, Greensboro, NC. 
Methylmercury hydroxide (Alfa Division, Ventron Corporation, Danvers, MA) 
was administered at two different doses (0.5 and 1.5 mg/kg body weight/day) 
to the appropriate groups of rats by gavage. The dose required for two 
days for each rat was combined and administered every other day. 
Treatments 
The eighteen treatments shown in Table 3, were achieved by adding 
atrazine to the appropriate diets (diets A, B, C, Table 2) with 
thorough mixing and oral administration of methylmercury hydroxide. 
Behavioral Tests 
Four behavioral test chambers were used to shape and train rats 
to respond to light stimuli. The test chamber (Figure 5) is constructed 
of Plexiglas^ and equipped with a barred floor, side door, variable 
intensity light, and an intelligence panel. Mounted on the intelligence 
panel are two IEEE in line stimulus projectors. A water reinforcement 
fount and response bar are located directly below each projector. 
Each plexiglas chamber was mounted in a sound proof wooden 
enclosure with plexiglas window. A closed circuit television camera was 
mounted outside of the chamber in front of the chamber window. The presen­
tation of the light stimuli and reinforcement was computer controlled: 
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Computer Instrumentation and Program The computer used for 
experimental control and data acquisition was a Digital Equipment Corpora­
tion (DEC) PDP-8/A with a dual floppy disk drive, buffered digital input/ 
output interface. Output signals from the plugboard in each chamber were 
connected to the computer interface- Each chamber used two input channels, 
one for each response bar, a total of eight input channels were used for 
operating channels. A standard teletype was used to provide experimenter 
interaction with the computer. 
A computer program written in the Program Assembly Language (Hopper, 
1976) with a minor modification was used to control shaping and testing. 
Shaping of Rats in the Pre-exposure Phase Shaping was carried out 
by reinforcing bar press responses during the light stimulus. A correct bar 
press response was reinforced by 0.1 ml of sweetened water (0.08 ml of 0.04 
g sugar per ml of water), either by an observer or under computer control. 
An incorrect response was not reinforced and terminated the trial. 
Each rat was trained once daily for a total of 20-26 training 
sessions during response shaping period. Each session lasted approximately 
eight minutes and consisted of 42 trials which began with an intertriai 
interval (ITI) , during which both stimulus lights remained darkened. 
Following the ITI one of the lights was lighted and remained on until a 
correct or incorrect response was made, or until it was automatically 
terminated by the computer program after elapse of 10 seconds, whereupon 
the trial was defaulted and the next trial was started. 
At the end of each training session, a quick reference data 
summary was printed under computer control. It included a list of delays 
employed during the training session, the number of correct and 
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Figure 6. Behavioral test chamber 
^Sweetened water reservoir. 
^Light stimulus display. 
^Response keys. 
^Reinforcement cups. 
^Variable intensity house light. 
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Table 2. Sulfur amino acid concentration of experimental diets 
Diet % sulfur amino acid concentration % of 
methionine cystine total requirement 
A (basal + 0.24% L-met) 0.42 0.18 0.60 100 
B (basal) 0.18 0.18 0.38 60 
C (basal + 0.48% L-met) 0.66 0.18 0.84 140 
Table 3. Composition of treatments 
Treatment Diet Atrazine mg/kg diet Hg mg/kg body wt. 
1 A  0 0 
2 B 0 0 
3 C 0 0 
4 A 0 0.5 
5 B 0 0.5 
6 C 0 0.5 
7 A 0 1.5 
8 B 0 1.5 
9 C 0 1.5 
10 A 500 0 
11 B 500 0 
12 C 500 0 
13 A 500 0.5 
14 B 500 0.5 
15 C 500 0.5 
16 A 500 1.5 
17 B 500 1.5 
18 C 500 1.5 
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incorrect responses, the number of defaults to the left and right stimulus 
lights, the number of spontaneous responses during stimulus presentation, 
and the intertriai interval. 
Two-choice Form Discrimination Test in Exposure Phase Tests 
were started a day after exposure to toxicants. The behavioral chambers 
were used and random light stimuli in triangle and square patterns with 
equal light intensity were presented in this test. 
The pattern which was rewarded by sweetened water was the triangle 
which appeared randomly on either the right or the left side of the intelli­
gence panel simultaneously with the square pattern on the other side of the 
panel. Correct responses were recorded by pressing of the pedal under 
the triangle illuminated pattern. Incorrect response were recorded by 
pressing of the pedal under the square illuminated pattern. 
The two-choice form discrimination test was conducted once a 
day for each rat, with a total of 25-29 sessions in the exposure phase 
of the experiment. Each session consisted of 42 trials. The course 
of each session was similar to that described for shaping sessions with 
one exception, two lights were presented in the form of a triangle and 
a square. Following each session a short data summary similar to the 
one described for the shaping session was printed and a longer trial-by-
trial data summary was recorded in one disk and later transferred to^tape. 
Urine Collection 
During the exposure phase of the experiment, urine of rats was 
collected three times, as mentioned on page 38. Urine was collected on 
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wrinkled heavy duty aluminum foil for 8-10 hours in the dark period 
(Black and Claxton, 1979). Hanging type stainless steel wire mesh rat 
cages (20 x 24 x 20 cm) were used for this purpose and only distilled 
water was available to :the rats during this period. Collected urine was 
frozen at -20° until it was analyzed for mercapturic acid and mercury 
content. 
Necropsy and Sample Collection 
All rats were anesthetized with ether and the abdominal cavities were 
exposed by longitudinal incision on the midline of the abdomen. The 
following samples were collected: 
Blood was collected from vena cava. A four ml sample was 
collected in a 10 ml disposable polyethylene syringe containing two drops 
of heparin (Sigma Company, St. Louis, MO) (1000 U/ml deionized water of 
Na heparin) for enzyme and mercury analysis. The blood was then delivered 
to polyethylene tubes containing acid-citrate-dextrose (ACD). Another 
2 ml of blood was collected in a 10 ml polyethylene disposable syringe 
and incubated for 10 min. at 37° in a shaking waterbath. After exactly 
10 min., 0.1 ml sodium salicylate solution (4.2 mM sodium salicylate 
in 0.1 M potassium phosphate buffer pH 7.4) per ml of whole blood was 
added. Serum was obtained by centrifugation at 4° and immediately frozen 
and kept at -20° for prostaglandin analysis. 
Livers were perfused with cold 0.9% saline in situ to remove 
blood. The liver was excised, weighed, divided into four pieces, which 
were wrapped separately in aluminum foil. The samples were immediately 
frozen in liquid nitrogen and stored at -80° for GSH-Px, GSH-Rd, GSH-S 
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trans, and total glutathione analysis and at -20° for mercury analysis. 
Kidneys were removed, weighed, frozen in liquid nitrogen and 
stored at -20°. The cortex and medulla of the kidneys were used for 
mercury analysis. 
Whole brains were removed, frozen in liquid nitrogen and stored 
at -20°. The right occipital lobe was used for mercury analysis. 
Analytical Methods 
Tissue Composition and Enzymes 
Glutathione peroxidase specific acitvity Whole blood ACD 
was used to measure GSH-Px by the method of Paglia and Valentine (1967). 
Changes in absorbance (A) per min. on the linear portion of the curve was 
measured and units of GSH-Px per ml of whole blood were calculated as 
_ , (A sample - A blank) x 0.48231 dilution 
GSG-Px, unit/ml blood = ^ ml of sample ^ factor 
GSH-Px of liver was measured by the modified method of Pierce and Tappel 
(1978) and assisted by a personal communication from Dr. Shirley C. Chen, 
Department of Food and Nutrition, Iowa State University, Ames, lA. Instead 
of using hydrogen peroxide, T-butyl hydroperoxide (0.05 ml of 1.5 mg/ml 
per assay) was used as a substrate. 
Glutathione Reductase specific activity Activity of this 
enzyme in liver was measured using the method presented in Methods of 
Enzymatic Analysis (Bergmeyer and Gawehn, 1974). 
Glutathione-S-transferase specific activity This enzyme was 
measured by the method of Booth et al. (1961) and by adapting Ae for 
l,2-dichlor-4-nitrobenzene from Habig et al. (1974) for the calculation of 
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enzyme activity. 
Total protein In order to calculate the specific activities 
of enzymes, the total protein of supernatants prepared from liver samples 
was assayed using Biuret reagent (White et al., 1976). The specific 
activity of enzymes was calculated using the formula described by 
Bergmeyer (1978). 
Total glutathione Total glutathione in blood and liver was 
calculated by measuring GSH and GSSG by the fluorometric method of Hissin 
and Hi If (1976) . Addition of whole blood into a tube containing meta-
phosphoric acid and phosphate EDTA buffer resulted in hemolysis and 
breakdown of blood cells. Therefore, the homogenization step was 
omitted for the whole blood supernatant preparation. 
Mercapturic acids Urine mercapturic acid was estimated by 
measuring -SH group concentration before and after alkaline hydrolysis 
of urine. The method of Ellman (1959) was used for the determination of 
-SH group concentration. The sulfhydryl bond of mercapturic acid 
derivatives was hydrolyzed by the addition of 0.5 ml of 2îî NaOH into 
the diluted urine and incubated at 60° for 10 minutes. 
Mercury analysis Mercury in blood, brain, liver, kidney, and 
urine was measured by using the modified flameless atomic absorption spec-
trophotometric method of Leong and Ong (1971), with assistance of personal 
communication from Dr. Henry M. Stahr, Veterinary Diagnostic Laboratory, 
Iowa State University, Ames, lA. The method involved an oxidation of a 
known amount of sample in nitric acid at 50-60° overnight in Hypovials^ 
sealed with a teflon disk, a silicon rubber disk, and an aluminum seal. The 
clear digested sample after proper dilution was placed in a sample bottle 
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and 10 ml of 10% stannous chloride was added to it. A closed air 
aspirator carried volatilized mercury to a gold screen where it was 
collected by amalgamation for 2h minutes. Heat then was applied to the 
amalgam and the mercury was volatilized quickly and produced a sharp 
peak on a strip chart recorder. All glassware was acid washed in 50% 
nitric acid. 
Mercury stock solution was prepared by dissolving methylmercury 
hydroxide in 50 ml redistilled nitric acid and dilution to a volume of 1 
liter. Mercury intermediate solution (100 ug Hg/ml) was prepared by 
dilution of 10 ml of stock solution to 100 ml. Mercury working standard 
(1 ng Hg/ml) was prepared daily by dilution of 1 ml of intermediate 
standard solution to 100 ml. A series of standards (25, 50, 100, 150 ng 
Hg) was run with every 10 samples analyzed. 
Prostaglandin analysis PGE^ and TXB^ in serum was 
measured by radioimmunoassay as described by Hwang et al. (1976) and 
McCosh et al. (1976). The method involved precipitation of each PG with 
specific antiserum and anti rabbit gasima globulin. The PGE^ antisera 
had a cross reactivity of 15% with PGEg and TXB^ antisera did not show 
any cross reactivity. Standards were a gift from the Upjohn Company 
(Kalamazoo, MI) . Tritiated PGE^ and TXB^ were purchased from New 
England Nuclear (Boston, MA). 
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Statistical Analysis 
Results of the clinical and biochemical studies were analyzed by 
factorial analysis of variances (Dr. David Cox, Statistical Laboratory, 
Iowa State University, Ames, Iowa), and means were compared by use of a 
least significant difference (LSD) test at the 5% level of probability 
(Snedecor and Cochran, 1967). 
Seven variables from the behavioral studies, namely : number of 
correct responses (CR), number of incorrect responses (IR), number of 
defaults, total time for correct responses (TTCR), and average time 
of incorrect responses (ATIR), were analyzed by split plot factorial 
analysis of variances (Dr. David Hopper, Behavioral Toxicology Division, 
Veterinary Diagnostic Laboratory, Iowa State University, Ames, Iowa). 
In the original design of the e:^eriment, 29 testing sessions were 
planned for each rat during the e:^osure phase. Some of the rats 
died prior to the last testing session. Since data from sessions 1 to 
27 were available for the majority of the rats, these data were used 
for analysis of the effect of treatments as well as testing session on 
the variables. Because of limitations in the capacity of computer 
memories, data of alternate testing sessions from session ]_ to 27 for 
a total of 14 sessions were used and summarized in order to ran split 
plot factorial analysis of variance. Means of different variables 
were compared for treatment effects by the use of the LSD test at a 
5% level of probability. 
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RESULTS 
Results of Clinical and Biochemical Studies 
The treatment of groups of rats with a total of 18 different treat­
ments which contained combinations of three levels of dietary methionine 
(diets A, B and C, Table 2), two levels of atrazine (-atrazine = 0.0 mg, 
+atrazine = 500 mg/kg of diet. Table 3), caused significant changes in the 
rats general appearance, and in physiological, biochemical and behavioral 
parameters. 
The major observable drastic health alteration resulted from methyl-
mercury hydroxide (MeHg) toxicity. Administration of high methylmercury 
hydroxide (MeHg^) for five weeks in the group which received three 
different diets with or without atrazine, resulted in the occurrence of 
classic signs of MeHg toxicity in rats in the following progression: 
roughness of fur, alteration of gait, decrease of food intake, subtle 
widening of hindlimb placement, loss of weight, progressive ataxia, 
dragging and wide spacing of hindlimb during ambulation, crossing 
phenomenonhematuria, frontlimb ataxia, and death. 
A decrease of observable food intake in these groups was detected 
at the fourth week of exposure following alteration of gait. The onset of 
MeHg toxicity signs at about the fourth week of e^osure was approximately 
4-5 days earlier in the groups which received both atrazine and MeHg^, 
^Crossing phenomenon is an exaggerated adduction with crossing over 
the hind limb while the rat is suspended by the tail. 
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The groups of rats treated with low levels of me thy Inter cury 
hydroxide (MeHg^), except for the roughness of fur, did not show other 
signs of MeHg toxicity after five weeks of exposure. A decrease in 
food intake due to MeHg^ or atrazine treatment was not detectable in 
these groups by daily observations. 
A total of six rats died in the course of the experiment. Only one 
rat died due to the method of application of MeHg. The loss of rats 
before the termination of the experiment in the groups receiving MeHg^ 
and atrazine was higher than that of those treated with MeHg^ alone. 
Table 4. The effect of dietairy methionine, methyLmercury hydroxide 
and atrazine on the percent weight gain^ of rats (mean ± SE, 
n=7.44, LSD=10.13) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
76.66 ± 12.50 
70.90± 5.53 
81.40 ± 6.24 
54.21±12.90 
67.37±7.19 
55.17 ± 6.24 
85.8G±13.80 
43.39+ 5.26 
84.59+ 6.15 
69.59+ 8.38 
80.41+ 9.70 
80.99±15.49 
MeHg^ 
-Atrazine 4.35 ± 9.97 24.05 ± 7.24 42.53±15.34 
+Atrazine 21.53±10.00 -1.54±9.09 -0.63± 9.56 
^Significant effect of Met (P < 0.01), MeHg (P < 0.01), Atrazine 
(P < 0.01) and Met x MeHg x Atrazine (P < 0.05). 
^MeHg 1=0.0 mg, MeHg2=0.5 mg, MeHg3= 1.5 mg Hg/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
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There was a significant effect of dietary methionine (Met), 
MeHg, and atrazine treatments as well as their interactions on weight 
gain (Table 4) . Weight gain mean comparisons indicated that administra­
tion of MeHg caused a decrease in weight gain. Animals fed diet B had 
a significant decrease of weight gain, but with administration of MeHg^ 
and MeHg^, diet B did not cause such weight reduction in comparison to 
Table 5. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on liver weight (% body weight)^ of rats 
(mean ± SE, n=7.06, LSD=0.21) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atarzine 
MeHg 2 
-Atrazine 
+Atrazine 
2.80 ± 0.10 
3.14 ± 0.14 
3.00 ± 0.20 
3.14 ± 0.22 
3.40 ± 0.25 
3.15 ± 0.26 
2.94 ± 0.15 
3.33 ± 0.11 
3.29 ± 0.21 
3.18 ± 0.16 
3.47 ± 0.14 
3.59 ± 0.33 
3.11 ± 0.29 
3.04 ± 0.14 
3.22 ± 0.19 
2.95 ± 0.19 
3.12 ± 0.22 
3.28 ± 0.22 
a Significant effect of MeHg (P < 0.10). 
b 
MeHg =0.0 mg, MeHg^=0.5 mg, MeHg =1.5 mg Hg/kg body weight, and 
-Atrazine=cr.0 mg, +Atrazirie=500 mg/kg diet. 
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the groups receiving diet A and C and MeHg. Administration of atrazine 
in the diet to the rats receiving diet B also resulted in a decrease in 
weight gain. In the groups which received MeHg^» only the groups which 
were fed diet C without atrazine showed a greater weight gain in 
cOTiparison to those which received both MeHg, atrazine and diet C. 
Table 6. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on the kidney weight (% body weight)^ of rats 
(mean ± SE, n=7, LSD=0.11) 
Toxicant* Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
0 . 6 8  ±  0 . 0 2  
0.97 ± 0.18 
0.81 ± 0.03 
0.91 ± 0.04 
1.57 ± 0.15 
1.66 ± 0.19 
0.70 ± 0.02 
0.89 ± 0.04 
0.85 ± 0.03 
0.92 ± 0.03 
1.54 ± 0.13 
1.94 ± 0.13 
0.72 ± 0.02 
0.81 ± 0.04 
0.85 ± 0.03 
0.86 ± 0.03 
1.40 ± 0.13 
1.69 ± 0.29 
Significant effect of MeHg and atrazine (P < 0.01). 
^MeHg]_=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg Hg/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
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Liver and kidney weights as percent of body weight at the end of 
the experiment were calculated and are shown in Tables 5 and 6, respec­
tively. There were no statistically significant differences among the 
means of liver weight as percent of body weight due to dietary Met and 
atrazine treatments (Table 5). The response of kidney to the treatments 
was more pronounced than that of liver. The effect of both MeHg and 
atrazine on excess kidney weight was highly significant (Table 6) . This 
effect was more distinct in the groups of rats treated with 1.5 mg MeHg. 
Dietary methionine did not affect kidney weight. 
The mean concentrations in the blood, liver, kidney and brain of 
treated rats are shown in Tables 7, 8, 9, and 10, respectively. When 
MeHg^ was administered, the occipital lobe of rat brain accumulated a 
larger amount of mercury per gram of tissue in ccxnparison to the other 
tissues. 
The concentration of mercury in the blood was significantly affected 
by MeHg treatment as well as by its interaction with dietary Met (Table 7). 
The addition of atrazine to the diet did not cause a significant change in 
blood mercury concentration. As the dose of MeHg increased, the mean 
blood mercury increased greatly. The Met deficient diet (diet B) 
produced a significant increase of blood mercury only in the groups of 
rats treated with MeHg^. 
The concentration of mercury in the liver was significantly increased 
with increasing dosage of MeHg (Table 8). Mean comparisons of liver 
mercury concentration revealed that only those groups treated with MeHg^ 
showed a significant increase of mercury concentration in the liver due to 
the presence of atrazine in the diet. There was no significant effect of 
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dietary methionine treatments on the accumulation of mercury in the liver. 
The kidneys of groups of rats that were fed diets A, B, or C showed 
increases of mercury concentration in response to an increase in MeHg 
Table 7. The effect of dietary methionine, methylmercxiry hydroxide, 
and atrazine on the mercury concentration^ (ug/g) in the 
whole blood of rats (mean ± SE, n=6.66, LSD=66.5) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 0.0 0.0 0.0 
+Atrazine 0.0 0.0 0.0 
MeHg^ 
-Atrazine 166 ± 24 161± 23 174 ± 29 
+Atrazine 199 ± 42 182 ± 23 135 ± 26 
MeHg 2 
-Atrazine 560± 123 630± 62 588± 54 
+Atrazine 518 ± 97 824 ± 84 631± 103 
^Significant effect of MeHg (P < 0.01), and MeHg x Met (P < 0.10). 
b 
MeHgT_—0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg Hg/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
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Table 8. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on the mercury concentration^ (ug/g) in the 
liver of rats (mean ± SE, n=6.58, LSD=17.2) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
0 . 0  
0 . 0  
20.2 ± 1.0 
30.6 ± 7.1 
87.7 ±14.2 
128.6 ±27.9 
0 . 0  
0 . 0  
31.9 ± 3.0 
28.0 ± 1.9 
111.0 ±10.5 
121.6 ±26.6 
0 . 0  
0 . 0  
23.2 ± 1-7 
22.7 ± 1.9 
86.0 ±12.1 
158.6 ±52.0 
^Significant effect of MeHg (P < 0.01), atrazine (P < 0.05) and 
MeHg x atrazine (? < 0.10). 
^MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg Hg/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
60 
dose (Table 9). The addition of atrazine to the diet had no significant 
effect on kidney mercury concentration. Diet B, in the groups of rats 
treated with MeHg^/ caused a significant accumulation of mercury in 
kidney compared to those which received MeHg^ and diets A or C. However, 
groups of rats that were fed diet B and treated with MeHg^ showed a 
lower accumulation of mercury in the kidney as compared with those which 
were treated with MeHg^ and diet A or C-
Mercury concentration in the occipital lobe was increased 
significantly only by an increase in the dose of MeHg (Table 10) ; dietary 
methionine and atrazine did not have significant effects. 
Urinary excretion of mercury for 12-14 hours at periods I, II and 
III (urines which were collected after 1, 3, and 5 weeks of administration 
of MeHg and atrazine) is shown in Tables 11, 12, and 13, respectively. 
At the end of period I, the excretion of mercury was significantly 
increased by an increase in dose of MeHg (Table 11). There were no 
significant effects of dietary methionine and atrazine on urine mercury 
excretion during this period. 
Analysis of mercury content of urine collected during period II 
indicates the excretion of mercury was significantly increased due to 
an increase of MeHg dose (Table 12) except for the rats fed diet A with 
atrazine and treated with MeHg^ and MeHg^. 
The administration of atrazine in the diet of rats fed diet A and 
treated with MeHg^, caused an increase in mercury excretion in the urine 
during period II. Although the mean urine mercury excretion of the group 
fed diet C, MeHg^ and atrazine was 1.5 times higher than that of the 
group fed diet C, MeHg^ and no atrazine, this increase was not statis-
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Table 9. The effect of dietary methionine, methylmerciiry hydroxide 
and atrazine on the concentration of mercury^ (ug/g) in 
kidney of rats (mean ± SE, n=6.67, LSD=16.5) 
Toxicant* Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
0 . 0  
0 . 0 .  
85.5 ± 4.4 
104.8 ± 3.7 
190.4 ±23.9 
181.2 ±24.9 
0 .0  
0 . 0  
147.2 ± 22.6 
118.7± 6.6 
171.4± 9.9 
167.6 ± 17.6 
0.0 
0.0 
122.7 ± 12.5 
100.2 ± 11.2 
187.5 ± 9.0 
209.7± 11.8 
^Significant effect of MeHg (P < 0.01) and MeHg x Met (P < 0.05). 
^MéHg2=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg Hg/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
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Table 10. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on the mercury concentration^ (ug/g) in the 
occipital lobe. (mean ± SE, n=6.83, LSD=55.6) 
Toxicant Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
0 . 0  
0 . 0  
6.2 ± 1.1 
9.4 + 1,2 
46.0 ± 7.7 
52.9 ± 9.6 
0 . 0  
0 . 0  
8.5 ± 0.6 
7.8 ± 1.1 
51.3 ± 2.0 
50.2 ± 6.6 
0 . 0  
0 . 0  
9.2 + 0.9 
9.1 ± 1.0 
42.6 + 6.8 
55.7 + 12.0 
^Significant effect of MeHg (P < 0.01). 
^MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg Hg/kg body weight, and 
-Atrazine=0-0 mg, +Atrazine=500 mg/kg diet. 
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Table 11. The effect of dietary methionine, methylmerciiry hydroxide, 
and atrazine on urine mercury excretion^ (nq/dav) during 
period I (mean ± SE, n=7.08, LSD=93.4) 
Toxicant ^  Diet A Diet B Diet C 
MeHg^ 
-Atrazine 0.0 0.0 0.0 
+Atrazine 0.0 0.0 0.0 
MeHg^ 
-Atrazine 90.2 ± 31.6 63.3 ± 20.6 78.7 ± 29.7 
+Atrazine 133.7 ± 34.4 100.4 ± 47.8 56.0 ± 25.2 
MeHg 2 
-Atrazine 220.1 ± 55.3 155.4 ± 40.6 329.1 ± 70.9 
+Atrazine 527.2 ±137.3 383.7 ±194.0 217.7 ± 67.4 
^Significant effect of MeHg (P < 0.01). 
^MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg/kg body weight, and 
-Atrazine-0.0 mg, +Atrazine=500 mg/kg diet. 
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Table 12. The effect of dietary methionine, methylmercury hydroxide 
and atrazine on urine mercury excretion^ (ng/day) during 
period II (mean ± SE, n=7.25, LSD=434) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
0 . 0  
0 . 0  
1066.0 ± 374.5 
1043.4 ± 245.1 
991.4 ± 388.2 
1691.8± 749.2 
0 . 0  
0 . 0  
298.4± 135.7 
740.4 ± 140.4 
1158.7 ± 349.1 
2725.1± 791.5 
0 . 0  
0 . 0  
501.7 ±178.3 
676.4 ±136.3 
1045.0 ± 342.0 
1456.4 1 367.7 
^Significant effect of MeHg (P < 0.01) and Atrazine (P < 0.05). 
^MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
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Table 13. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on urine mercury excretion^ (ng/day) during 
period III (mean ± SE, n=6, LSD=383) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
0 . 0  
0 . 0  
434.7 ± 163.9 
1189.0 ± 251.1 
1645.8 ± 420.8 
16.7.7 ± 337.8 
0 , 0  
0 . 0  
843.5 ± 218.2 
904.7± 120.5 
1218.7±436.3 
1774.2± 514.5 
0 . 0  
0 . 0  
1389.4± 145.3 
812.4 ± 185.5 
1472.0 ± 436.8 
1584.0 ± 514.0 
^Significant effect of MeHg (P < 0.01). 
^MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mgk/g diet. 
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cally significant. The overall effect of atrazine treatment during period 
II on urine mercury excretion was more pronounced in the groups which 
received high doses of MeHg than those which received low doses of MeHg. 
Dietary methionine by itself did not have a significant effect on urine 
mercury excretion during this period. 
The mean urine mercury excretion during the period III is shown in 
Table 13. The administration of high doses of MeHg caused an increase 
in urinary excretion of mercury during this period. This effect was 
uniformly seen in the groups of rats fed any of the three diets with 
atrazine. The increase in urine mercury excretion due to the high dose 
of MeHg was also significant in groups of rats which were fed diet A 
without atrazine. Comparison of the means of urinary mercury excretion 
by groups of rats at different periods indicates that, generally, mercury 
excretion in urine increased as the number of days of exposure to MeHg 
increased. This trend was more consistent in the groups of rat which 
received atrazine in their diet. 
The activity of whole blood glutathione peroxidase (GSH-Px) was 
significantly decreased with an increase in MeHg dose (Table 14) . Mean 
enzyme activity (Table 14) showed an increase of activity related to 
atrazine treatment. Significant differences were found for rats which 
were fed diet C and no MeHg, and in groups fed diet B or C with MeHg^. 
Feeding rats with diet A, with or with atrazine, and MeHg^ resulted 
in a highly significant increase in the specific activity of the enzyme 
GSH-Px of the liver in comparison with the two other dietary groups. Rats 
which were fed diet B showed a lower liver GSH-Px activity than did groups 
fed diets A or C. However, the lower activity of enzyme was statistically 
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Table 14. The effect of dietary methionine, methylmercury hydroxide 
and atrazine on whole blood glutathione peroxidase activity^ 
(U/ml) (mean ± SE, n=7, LSD=2.7) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 31. 95 ± 2. 47 35. 67 ± 2. 32 31. 75 ± 1. 14 
+Atrazine 31. 84 ± 2. 04 35. 31+ 3. 08 39. 34+ 2. 36 
MeHg^ 
-Atrazine 25. 70 ± 2. 71 22. 16 + 2. 48 26. 51± 5. 08 
+Atrazine 27. 66 ± 1. 77 31. 23 ± 2. 56 30. 18 ± 3. 34 
MeHg^ 
-Atrazine 24. 11+ 3. 59 18. 35 + 0. 93 21. 85 ± 1. 74 
+Atrazine 24. 71+2. 25 20. 29 ± 1. 20 22. 75 ± 2. 14 
^Significant effect of MeHg (P < 0.01) and atrazine (P < 0.05). 
^MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
significant only in the group which was also treated with atrazine or MeHg^-
Rats fed diet C alone had a significant increase in enzyme activity in 
comparison with rats fed the other diets. The rats which received diet C 
with MeHg^ and no atrazine also showed a higher enzyme activity compared 
with those which received diet B with MeHg and no atrazine. 
A factorial analysis of variance did not indicate any significant 
effects of either toxicant on liver GSH-Px. Least significant difference 
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Table 15. The effect of dietary methionine, methyMercury hydroxide, 
and atrazine on liver glutathione peroxidase activity^ 
(xlO~^U/g) in rats (mean ± SE, n=7.06, LSD=1.77) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
6.14+ 1.40 
7.58+ 1.10 
8.65 ± 1.29 
8.08 ± 0.93 
10.47 ± 1.63 
11.58 ± 2.87 
6.46 ± 1.65 
5.86 ± 0.54 
7.98 ± 1.98 
8.47 ± 1.07 
6.25 ± 1.72 
8.06 ± 1.39 
11.64± 3.32 
7.67+0.89 
9.97 ±1.43 
9.35 ±1.24 
9.22 ±1.22 
9.53 ±1.50 
^Significant effect of met (P < 0.05). 
^MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 rr.g/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
tests, however, showed some inconsistent and non-directional effects 
of atrazine and MeHg on the specific activity of this enzyme in liver. 
The activity of liver glutathione reductase (GSH-Rd) which reduces 
oxidized glutathione, was not affected by any of the treatments (Table 16). 
The measurement of the specific activities of glutathione-S-transferases 
(GSH-S-trans) of rat liver for conjugation of reduced glutathione and 1,2-
dichloro-4-nitrobenzene revealed that there was a statistically signif-
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Table 16. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on liver glutathione reductase activity 
(xlO"4 u/g) in rats (mean ± SE, n=6.94, LSD=1.77) 
Toxicant Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
3.20 ± 0.80 
4.04 ± 0.94 
4.40 ± 1.05 
5.37 ± 1.48 
4.82 ± 1.02 
4.47 ± 0.99 
3.77 ± 0.98 
4.50 ± 1.29 
3.72 ± 0.82 
4.14 ± 1.09 
5.37 ± 1.58 
6.10 ± 2.69 
3.92 ± 0.85 
4.34 ± 0.87 
3.30 ± 1.70 
4.08 ± 1.13 
5.19 ± 1.28 
4.95 ± 1.59 
^MeHg^=0.0 mg, MeHg2=0.5 mg, MeHg2=1.5 mg/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
leant effect of MeHg auid atrazine and an interaction effect of MeHg 
and dietary Met on the activity of the enzymes (Table 17). Administration 
of low or high levels of MeHg in rats fed diet A or B, caused decrease 
and increase of specific activity of this enzyme in liver respectively. 
The effects of MeHg were exaggerated in rats fed diet A with MeHg^ and in 
rats fed diet B with MeHg^- In the groups fed diet C, the administration 
of MeHg^ and MeHg^ caused an increase and a decrease of enzyme specific 
activity, respectively. Feeding the Met deficient diet (diet B) resulted 
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Table 17. The effect of dietary methionine, methylmerciiry hydroxide, 
and atrazine on the activity of liver glutathione-S-trans-
ferases^ (U/g) in rats (mean ± SE, n=6.89, IiSD=2.96) 
Toxicant ^  Diet A Diet B Diet C 
MeHg 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
31.00 ± 4.88 
26.74 ± 2.40 
30.29 ± 3.04 
24.44 ±1.95 
25.03 ± 2.27 
23.15 ± 2.69 
26.17 ± 2,21 
20.35 ± 3.05 
36.87 ± 2.12 
26.96 ± 3.31 
31.01± 2.23 
26.81± 2.64 
33.41+ 3.39 
26.91± 3.57 
36.83 ± 2.39 
25.27±2.24 
27.41+ 2.25 
21.25 ± 2.05 
Significant effect of MeHg (P < 0.05), MeHg x met (P < 0.01) and 
atrazine (P 0.01). 
y 
MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg/kg body weight, and 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
in a decrease in activity of GSH-S-trans in rats treated with or 
without atrazine and no MeHg, i.e. MeHg^. However, enzyme activity 
was high when MeHg^ or MeHg^ was administered in groups fed diet B with 
or without atrazine in the diet. The groups which received atrazine 
in their diet showed a significant decrease in liver GSH-S-trans specific 
activity in comparison to those which did not receive atrazine. 
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Table 18. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on prostaglandin E concentration^ (ng/ml) 
in serum of rats (mean ± SE, n=b.72, LSD=0.86) 
Toxicant ^  Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
0.88 ± 0.19 
1.29 ± 0.43 
1.22 ± 0.28 
1.88 ± 0.27 
3.32 ± 1.29 
2.59 ± 0.46 
1.48 ± 0.43 
2.10 ± 0.99 
1.74 ± 0.37 
1.56 ± 0.21 
4.82 ± 1.67 
5.61 ± 1.52 
1.05 ± 0.24 
2.00 ± 0.58 
2.28 ± 0.48 
1.29 ± 0.32 
4.46 ± 1.24 
3.70 ± 1.12 
^Significant effect of MeHg (P < 0.01) and Met (P < 0.10). 
^MeHg3^=0.0 mg, MeHg2= 0.5 mg, MeHg =1.5 mg/kg body weight, and 
-Atrazine=0.0 mg/kg diet, +Atrazine=500 mg/kg diet. 
A significant increase in ex-vivo synthesis of prostaglandin E^ 
(PGE^) in blood caused by increasing MeHg dose is shown in Table 18. 
Dietary Met has a slight effect on ex-vivo synthesis of PGE^. Although, 
as shown in Table 18, the rats receiving diet B showed an elevated mean 
serum PGE^ concentration, only in the group which received diet B, MeHg^ 
and atrazine did the elevation of PGE^ in the serum reach statistical 
significance in comparison to the groups which were fed diet A or C with 
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Table 19. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on thromboxane B2 concentration^ (ng/ml) 
in serum of rats (mean ± SE, n=5.56, LSD=31.2) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
19.1 ± 4.9 
52.7 ± 13.2 
42.3 ± 17.0 
24.0 ± 5.3 
34.9 ± 20.7 
49.4 ± 12.8 
34.2 ± 12.2 
24.9 ± 9.5 
45.1 ± 12.5 
45.7 ± 8.3 
157.4 ± 55.7 
208.9 ± 47.6 
27.5 ± 10.3 
48.0 ± 17.0 
116.4 ± 47.7 
26.5 ± 6.8 
180.7 ± 62.5 
172.9 ± 36.4 
^Significant effect of MeHg, Met and MeHg x Met (P < 0.01). 
b 
MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg/kg body weight, 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
MeHq^ and atrazine. Atrazine treatment had no significant effect on the 
ex-vivo synthesis of PGE^ in blood. 
Overall factorial analysis of variances for thromboxane (TXB^) 
concentration in serum of rats indicated a highly significant effect of 
MeHg, Met, as well as their interaction on the ex-vivo TXB^ synthesis 
in blood (Table 19). However, the least significant mean difference test 
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revealed that only the rats which were fed diet B or C, with MeHg^ or 
MeHg^, had a significant increase in ex-vivo synthesis of TXB^ in 
the blood. The high dose of MeHg also caused a significant increase 
in ex-vivo synthesis of TXB^ in the blood of groups receiving atrazine 
in diets B and C. The effect of MeHg on ex-vivo synthesis of blood 
TXB^ in rats fed diet A was not statistically significant. 
Analysis of whole blood reduced glutathione (GSH) showed a signif­
icant effect of MeHg, Met, atrazine and also an interaction of MeHg 
and atrazine treatments on the concentration of whole blood GSH at the 
end of the experiment (Table 20) . Except for the rats which were fed 
diet A with MeHg^ and MeHg^, all rats given atrazine in their diet had 
a significant increase of whole blood GSH after 5 weeks. The MeHg 
treatment effect was consistent on whole blood GSH in rats which 
received atrazine in the diet. MeHg^ and MeHg^ caused a decrease and 
increase in whole blood GSH respectively, in comparison to control rats. 
Although the overall factorial analysis of variance indicated a signif­
icant effect of dietary Met treatments on whole blood GSH, the mean 
comparison for least significant differences did not show any 
directional and meaningful trend on particular groups of rats. 
MeHg had a highly significant effect on rats whole blood oxidized 
glutathione (GSSG) (Table 21). Administration of MeHg^ in rats which 
were fed diet A, without atrazine, caused a significant decrease in 
whole blood GSSG, but such a response was not seen in the groups 
which received atrazine in the diet. MeHg treatments of rats 
receiving diet B or C without atrazine caused a significant decrease 
of whole blood GSSG. 
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Table 20. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on whole blood reduced glutathione^ (ug/ml) 
in rats (mean ± SE, n=7.17, LSD=0.12) 
Toxicant' Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
0.69 ± 0.15 
0.69 ± 0.09 
0.48 ± 0.16 
0.84 ± 0.07 
0.47 ± 0.11 
0.49 ± 0.19 
0.37 ± 0.09 
0.90 ± 0.08 
0.76 ± 0.11 
1.06 ± 0.06 
0.53 ± 0.11 
0.66 ± 0.13 
0.71 ± 0.04 
0.79 ± 0.09 
0.35 ± 0.08 
0.89 ± 0.18 
0.59 ± 0.12 
0.79 ± 0.15 
Significant effect of atrazine (P < 0.01), MeHg, Met and MeHg x 
atrazine (P < 0.05). 
MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg/kg body weight, 
-Atrazine=0.0 mg, and +Atrazine-500 mg/kg diet. 
Analysis of whole blood total glutathione (TGSH=GSH+GSSG) indicated 
a significant effect of MeHg and Met treatments as well as MeHg and 
atrazine interaction effect on TGSH (Table 22). Least significant 
differences of means in Table 22 indicated that MeHg caused a significant 
decrease of whole blood TGSH in rats which were fed diet A, B, or C 
without atrazine. In rats fed atrazine, MeHg^ caused a decrease of 
75 
Table 21. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on whole blood oxidized glutathione^ (ug/ml) 
in rats (mean ± SE, n-»7.17, LSD=0.07) 
Toxicant & Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
0.52 ± 0.06 
0.50 ± 0.05 
0.39 ± 0.02 
0.47 ± 0.07 
0.56 ± 0.05 
0.47 ± 0.08 
0.76 ± 0.15 
0.68 ± 0.05 
0.48 ± 0.03 
0.55 ± 0.06 
0.45 ± 0.08 
0.43 ± 0.06 
0.57 ± 0.03 
0.54 ± 0.08 
0.50 ± 0.14 
0.50 ± 0.05 
0.45 ± 0.06 
0.25 ± 0.05 
Significant effect of MeHg, MeHg x Met (P < 0.05) and MeHg x 
atrazine (P < 0.10). 
^MeHg]^=0.0 mg, MeHg2=0.5 ing, MeHg3=1.5 mg/kg body weight, 
-Atrazine-O.0 mg, +Atrazine=500 mg/kg diet. 
TGSH; whereas, MeHg^ caused an increase of TGSH of whole blood in the 
groups fed diet A or C with atrazine. Significant effects of dietary 
Met treatments were observed in the rats which were fed diet B, i.e., 
an increase of TGSH in whole blood when rats were treated with MeHg^ 
or MeHg^, with or without atrazine as compared with rats fed diet A or C. 
No significant effects of dietary Met were detected in the groups treated 
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Table 22. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on whole blood total glutathione^ (ug/ml) 
in rats (mean ± SE, n=7.17, LSD=0.15) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
1.21 ± 0.20 
1.19 ± 0.12 
0.88 ± 0.15 
1.31 ± 0.12 
1.03 ± 0.13 
0.96 ± 0.23 
1.56 ± 0.23 
1.59 ± 0.12 
1.24 ± 0.12 
1.61 ± 0.10 
0.99 ± 0.12 
1.09 ± 0.12 
1.28 ± 0.07 
1.33 ± 0.07 
0.86 ± 0.14 
1.52 ± 0.19 
1.05 ± 0.10 
1.04 ± 0.19 
^Significant effect of MeHg, Met, and MeHg x atrazine (P < 0.05). 
^MeHg2=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg/kg body weight, 
-Atrazine-0.0 mg, +Atrazine=500 mg/kg diet. 
with MeHg^. The elevation of TGSH in whole blood due to atrazine was 
significant only in the rats which were treated with MeHg^. Concentration 
of liver GSH, GSSG, and TGSH unexpectedly were not affected by either 
dietary treatments or toxicants (Tables 23, 24, and 25). 
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Table 23. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on liver reduced glutathione (ug/mg) in rats 
(mean ± SE, n=7.11, LSD=1.14) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHgg 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
2.28 ± 0.46 
2.89 ± 0.39 
2.24 ± 0.46 
2.48 ± 0.33 
2.36 ± 0.30 
3.21 ± 0.52 
2.21 ± 0.31 
2.10 ± 0.21 
2.11 ± 0.24 
2.71 ± 0.53 
2.92 ± 0.40 
2.72 ± 0.62 
3.01 ± 0.38 
2.59 ± 0.35 
2.42 ± 0.33 
2.51 ± 0.33 
2.67 ± 0.45 
2.24 ± 0.59 
^MeHg =0.0 mg, MeHg2=0.5 mg, MeHg2=1.5 mg/kg body weight, -Atrazine= 
0.0 mg, 4-Atrazine=500 mg/kg diet. 
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Table 24. The effect of dietary methionine, methylmercuryj hydroxide, 
and atrazine on liver oxidized glutathione^ (ug/mg) in 
rats (mean ± SE, h=7.11, LSD=0.89) 
Toxicant® Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
0.44 ± 0.12 
0.55 ± 0.12 
0,43 ± 0.07 
0.34 ± 0.08 
0.38 ± 0.08 
0.64 ± 0.14 
0.37 ± 0.09 
0.38 ± 0.09 
0.44 ± 0.11 
0.43 ± 0.13 
0.45 ± 0.08 
0.43 ± 0.06 
0.55 ± 0.11 
0.48 ± 0.07 
0.50 ± 0.10 
0.50 ± 0.05 
0.45 ± 0.06 
0.38 ± 0.07 
*MeHg^=0.0 mg, MeHg2=0.5 mg, MeHg2=1.5 mg/kg body weight, -Atrazine= 
0.0 mg, +Atrazihe=500 mg/kg diet. 
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Table 25. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on liver total glutathione^ (ug/mg) in rats 
(mean ± SE, n=7-ll, LSD=1.28) 
Toxicant 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
2.72 ± 0.56 
3.42 ± 0.45 
2.67 ± 0.45 
2.83 ± 0.35 
2.74 ± 0.33 
3.90 ± 0.63 
2.58 ± 0.36 
2.48 ± 0.26 
2.55 ± 0.31 
3.14 ± 0.64 
3.30 ± 0.45 
3.15 ± 0.65 
3.56 ± 0.42 
3.07 ± 0.36 
2.93 ± 0.38 
3.01 ± 0.33 
3.25 ± 0.51 
2 . 6 2  ±  0 . 6 0  
^iyieHg^=0.0 mg, MeHg2=0.5 mg, MeHg2=1.5 mg/kg body weight, -Atrazine= 
0.0 mg, +.^rtrazir.e=500 mg/kg diet. 
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Measurement of conjugated sulfhydryl groups as a crude estimator 
of mercapturic acids excretion in the urine across period I, II and III 
were also employed to obtain further information about the effects of 
treatments on glutathione metabolism in this experiment. The urinary 
excretion of mercapturic acids at different periods of time (periods I, 
II, and III) was affected significantly by administration of atrazine 
in the diet (Tables 26, 27, and 28). A significant increase of 
mercapturic acids excretion due to atrazine was observed in the urine 
collected during period I from rats treated with MeHg^ and rats 
treated with MeHg^ and fed diet A or B (Table 25) . Rats fed diet B 
and given MeHg^ also showed a significant increase of mercapturic acids 
excretion in urine during period I due to the presence of atrazine 
in the diet. 
Analysis of urine collected from rats during period II revealed 
that both MeHg and atrazine had a significant effect on urine mercapturic 
acids excretion (Table 27). With the exception of the groups which 
were fed diet A and no atrazine, the administration of MeHg^ caused 
a significant increase of mercapturic acid excretion in the urine of 
rats in comparison to the groups treated with MeHg^ or MeHg^ and were 
fed any of the three diets with or without atrazine. With respect to 
period I, the excretion of mercapturic acids in the urine was generally 
elevated during period II. 
There was a significant increase in mercapturic acids excretion 
in the urine of rats during period III due to atrazine in rats treated 
with no MeHg (Table 28). The effects of atrazine in the other groups 
which were treated with MeHg^ or MeHg^ were not significant, with 
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Table 26. The effect of dietary 
and atrazine on urine 
X 10~^.mol/day) during 
methionine, methylmercury hydroxide, 
mercapturic acid excretion^ (-SH 
period I (mean ± SE, N=7.61, LSD=4.35) 
Toxicant^ Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
H-Atrazine 
MeHgg 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
17.22 ± 0.20 
14.91± 3.05 
15.17 ± 2.67 
23.59 ± 5.17 
8.43 ± 2.62 
20.36 ± 8.49 
9.63 ± 1.22 
20.14 ± 5.71 
6.72 ±1.35 
14.50 ± 4.08 
8.29 ± 2.11 
16.93 ± 6.35 
15.33 ± 6.37 
10.58 ± 3.15 
11.07 ± 2.34 
11.18+ 3.24 
10.05 ± 2.51 
21.04 ±6.27 
^Significant effect of atrazine (P < 0.01). 
MeHg]_=0.0 mg, MeHg2=0-5 mg, MeHg3=1.5 mg/kg body weight, 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
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Table 27. The effect of dietary methionine, methylmercury hydroxide, ^ 
and atrazine on urine mercapturic acid excretion^ (-SH x 10 ^ 
mol/day during period II in rats (mean ± SE, n=7.44, LSD=5.48) 
Toxicant Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
27.97 ± 5.06 
25.46 ± 3.43 
30.02 ± 6.39 
38.80 ± 4.59 
29.64 ± 4.34 
25.60 ± 6.48 
25.43 ± 6.16 
29.95 ± 4.39 
36.69 ± 8.09 
38.82 ± 3.67 
26.47 ± 8.63 
28.31 ± 5.79 
25.36 ± 3.06 
30.80 ± 4.46 
30.11 ± 2.78 
35.08 ± 3.15 
15.20 ± 3.92 
29.67 ± 6.10 
^Significant effect of MeHg (P < 0.01) and atrazine (P < 0.10). 
^MeHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg/kg body weight, 
-Atrazine=0.0 mg, +Atrazine-500 mg/kg diet. 
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Table 28. The effect of dietary methionine, methylmercury hydroxide, 
and atrazine on urine mercapturic acid excretion^ (-SH x 
10~ mol/day) during period III (mean ± SE, n=6.67, LSD=5.84) 
Toxicant Diet A Diet B Diet C 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg 2 
-Atrazine 
+Atrazine 
8.14 ± 3.03 
17.33 ± 6.52 
18.58 ± 6.41 
19.00 ± 4.20 
15.97 ± 4.76 
18.19 ± 2.99 
10.96 ± 2.79 
26.12 ±10.45 
14.12 ± 3.30 
16.18 ± 3.63 
10.50 ± 3.23 
16.37 ± 5.84 
8.83 ± 4.17 
36.42 ± 8.51 
13.03 ± 3.93 
16.03 ± 2.04 
15.10 ± 3.96 
17.23 ± 7.87 
^Significant effect of atrazine (P < 0.01) and MeHg x atrazine 
(P < 0.05). 
^^eHgi=0.0 mg, MeHg2=0.5 mg, MeHg3=1.5 mg/kg body weight, 
-Atrazine=0.0 mg, +Atrazine=500 mg/kg diet. 
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the exception of rats fed diet B and treated with MeHg^. 
In the course of the experiment, the excretion of mercapturic 
acids in the urine of all groups generally increased until about the third 
week (period II) of the exposure phase, and thereafter, it decreased. 
The elevation of mercapturic acids excretion at period II was also 
observed with the groups of rats which did not receive the toxicant. 
A factorial analysis of variance for the effect of variables (MeHg, 
Met, and atrazine) and their interactions with each other on the clinical, 
and biochemical parameters are shown in Tables 29, 30, 31, and 32. The 
F values were tested for significance at P<0.01, P<0.05, and P<0.10 
and these values are designated with letters a, b, and c, respectively. 
Results of Behavioral Studies 
After a total of 20-26 training sessions in the pre-exposure phase, 
the average number of correct and incorrect responses in the last two 
training sessions of all groups of rats in both replicates were 28.86 and 
10.53, respectively. The average number of correct: and incorrect responses 
in the last two training sessions in both replicates are shown in Table 33. 
The factorial analysis of variance also indicates that none of the 
dietary methionine levels of toxicants alone had effects on the behavioral 
variables. Only the dietary methionine and atrazine interaction showed a 
significant effect on IR, TTCR and ATCR in one of the replicates (Tables 
34 and 35). Daily testing sessions had a highly significant effect on the 
behavior of rats during the e:^osure phase, and most of the variables 
showed significant effects at P< 0.01 (Tables 34 and 35). 
Table 29. Analysis of variance of % weight gain, liver and kidney weight as % of body weight 
and urine mercapturic acid excretion 
F value 
Source of 
variation df 
% wt. Liver wt. Kidney wt. Urine mercapturic acid 
gain % of B.W. % of B.W. I II III 
Mercury (Mer) 2 
Methionine (Met) 2 
Mer X Met 4 
Atrazine (Atr) 1 
Mer X Atr 2 
Met X Atr 2 
Mer X Met x Atr 4 
67.01 
3.01^ 
0 . 6 8  
16.27^ 
0.21 
1.03 
3.23^ 
2 . 6 8  
1.78 
0.20 
0.29 
0.81 
0.43 
0.75 
119.00 
1.03 
0.51 
12.32° 
. 1.42 
0 .28  
0.70 
0.02 
1.03 
0.97 
9.08^ 
1.38 
1.03 
0.61 
5.02 
0.55 
0.30 
2.64 
0.08 
0.73 
0.63 
a 
0.43 
0 . 2 2  
0.88 
8.24 
3.42^ 
0.76 
0.59 
^Significant effect of variation sources P < 0.01. 
^Significant effect of variation sources P < 0.10. 
"^Significant effect of variation sources P < 0.05. 
Table 30. Analysis of variance of blood and liver enzymes activity and prostaglandin synthesis 
in the blood 
F value 
Source of Blood Liver Liver Liver 
variation df GSH-Px GSH-Px GSH-Rd GSH-S-Trans TXB^ PGE^ 
Mercury (Mer) 2 35.39* 1.01 1.69 3.66^ 24.97® 20.12® 
Methionine (Met) 2 0.59 3.31^ 0.11 0.22 8.52® 2.49^ 
Mer X Met 4 1.53 0.98 0.50 3.90® 5.49® 0.99 
Atrazine (Atr) 1 5.49^ 0.10 0.71 26.09® 0.00 0.04 
Mer X Atr 2 0.85 0.94 0.14 1.23 2.05 0.58 
Met X Atr 2 0.71 0.54 0.02 0.36 1.05 0.27 
Mer X Met x Atr 4 0.99 0.17 0.08 0.30 0.80 0.47 
^Significant effect of variation sources P < 0.01. 
^Significant effect of variation sources P < 0.05. 
"^Significant effect of variation sources P < 0.10. 
Table 31. Analysis of variance of liver and blood glutathione 
F value 
Sources of 
variation df 
Liver 
GSH 
Liver 
GSSH 
Total 
liver 
glutathione 
Blood 
GSH 
Blood 
GSSG 
Total 
blood 
glutathione 
Mercury (Mer) 2 0.62 0.16 0.67 3.72^ 6.35b 7.58% 
Methionine (Met) 2 0.23 1.40 0.44 3.81^ 2.01 4.82% 
Mer X Met 4 0.87 0.61 0.88 1.52 3.81% 0.93 
Atrazine (Atr) 1 0.33 0.03 0.30 12.46*) 0.13 6.773 
Mer X Atr 2 0.30 0.27 0.19 3.37a 2.83C 5.0&3 
Met X Atr 2 1.23 1.39 1.54 0.47 0.03 0.19 
Mer X Met x Atr 4 0.43 1.06 0.59 0.17 0.52 0.27 
^Significant effect of variation sources P < 0.05. 
^Significant effect of variation sources P < 0.01. 
"^Significant effect of variation sources P < 0.10. 
Table 32, Analysis of variance of mercury concentrations in blood, liver, kidney, brain and urine 
F value 
Source of Blood Liver Kidney Brain Urine I Urine II Urine III 
variation df mercury mercury mercury mercury mercury mercury mercury 
Mercury (Mer) 1 16.75® 97.89® 66.91® 193.18® 18.00® 10.86® 10.57® 
Methionine (Met) 2 2.29 0.20 0.99 0.02 0.83 0.67 0.16 
Mer X Met 2 2.64^ 0.31 0
 
0
 0
 
0.06 0.19 1.93 0.35 
Atrazine (Atr) 1 0.98 5 . 7 3 C  0.18 1.43 2.48 5.I7G 0.58 
Mer X Atr 1 0.72 4.75b 0.61 0.84 1.43 2.10 0.12 
Met X Atr 2 2.10 1.13 0.64 0.57 2.15 0.91 0.98 
Mer X Met x Atr 2 2.10 0.93 1.53 0.45 1.11 0.29 1.45 
^Significant effect of variation sources P < 0.01 
^Significant effect of variation sources P < 0.10. 
"^Significant effect of variation sources P < 0.05. 
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Table 33. The average number of correct and incorrect responses of groups 
of rats at the last two training sessions of .the preexposure 
phase 
Diet A Diet B Diet C 
Toxicant Rep I Rep II Rep I Rep II Rep I Rep II 
MeHg 
- Atrazine 
+ Atrazine 
26b/13= 
29/12 
23/8 
26/12 
28/13 
28/13 
32/8 
27/10 
30/11 
32/9 
25/16 
29/9 
MeHg, 
- Atrazine 
+ Atrazine 
26/14 
30/10 
23/13 
35/5 
31/9 
28/11 
34/7 
30/9 
30/11 
26/14 
29/12 
25/9 
MeHg, 
- Atrazine 
+ Atrazine 
27/14 
34/8 
32/8 
31/7 
31/8 
26/15 
26/12 
32/9 
32/9 
32/9 
30/10 
25/12 
All groups were fed diet A without any toxicants during the pre­
exposure phase for 20-26 days after which they were fed the experimental 
diets (without atrazine) until the exposure phase, and were assigned to 
the different treatments as indicated in this table during exposure 
phase only. 
b 
Average number of correct responses. 
c 
Average number of incorrect responses. 
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Table 34 . Factorial analysis of variance for the effects of methylmercury hydroxide, dietary 
methionine, atrazine, and training session on the coded behavioral variables 
P value 
Correct response Incorrect response Default 
Treatments df I® 11^ I II I II 
MeHg 2 0.24 0.13 0.26 0.59 0.35 0.17 
Met 2 0.66 1.33 2.18 1.91 1.34 1.07 
Atr 1 1.28 0.91 0.51 0.89 0.04 1.47 
MeHg x Met 4 1.50 0.39 0,02 0.65 0.74 0.71 
MeHg X Atr 2 1.64 0.94 0.10 1.86 0.49 2.02 
Met X Atr 2 1.18 0.56 4.97^ 1.20 0.77 1.24 
MeHg X Met x Atr 4 0.46 0.71 0.51 0.55 0.67 0.57 
Training session (T) 13 3.38° 3.48° 4.49° 2.04° 1.76^ 2.65° 
T X MeHg 26 1.10 1.51 0.76 1.66 1.26 1.92° 
T X Met 26 1.04 1.02 1.11 0.96 0.98 1.07 
T X Atr 13 2.33° 0.80 0.67 0.91 1.37 0.91 
T X MeHg X Met 52 0.89 1.12 0.83 1.14 0.82 0.91 
T X MeHg x Atr 26 0.96 1.37® 1.06 1.51^ 1.20 0.98 
T X Met X Atr 26 0.77 0.95 0.87 0.65 1.80 0.80 
T X MeHg X Met x Atr 52 0.69 1.09 0.76 0.98 0.78 1.10 
^Replicate 
^Replicate 
< 0.01. 
< 0.05. 
®P < 0.10. 
I, n=3.89. 
I I ,  n=3 .78 .  
to  
Table 35. Factorial analysis of variance for the effect of methylmercury hydroxide, dietary 
methionine atrazine and testing sessions on the coded variables 
F value 
T.T. cor . res. T.T. inc. res. A.T. cor. res. A.T. inc. res. 
Treatment df 1* lib I II I II I II 
MeHg 2 0.27 0.74 0.19 0.17 1.24 1.42 0.67 0.93 
Met 2 0.45 2.31 1.08 1.13 0.13 1.08 1.32 1.11 
Atr 1 0.82 0.35 1.17 0.17 0.19 1.05 1.39 0.99 
Mellg X Met 4 1.66 0.27 0.15 0.55 1.20 0.35 1.06 0.40 
Mellg X Atr 2 0.66 0.34 0.13 1.64 0.25 1.19 0.46 0.92 
Met X Atr 2 4.16^ 1.02 1.68 1.52 1.89 0.45 3.27^ 0.57 
MeHg X Met x Atr 4 0.24 0.39 0.27 1.18 0.38 1.66 0.24 0.99 
Testing Session (T) 13 2.33° 0.74 5.81° 5.00° 1.28 10.12° 1.42 9.30° 
T X MeHg 26 0.87 1.41® 0.62 1.20 1.02 1.00 1.74 0.52 
T X Met 26 0.84 1.03 1.28 1.04 1.63 0.79 1.13 0.64 
T X Atr 13 1.71® 0.73 1.00 0.76 1.48 0.60 1.28 0.38 
T X MeHg x Met 52 0.79 1.32® 0.91 1.20 0.55 0.74 0.95 0.80 
T X MeHg X Atr 26 0.91 1.30 1.01 1.33 0.92 1.25 0.79 0.95 
T X Met X Atr 26 0.96 0.91 1.19 1.00 1.52^ 1.53^ 1.01 1.45® 
T X MeHg X Met x Atr 52 0.58 1.05 0.95 0.88 0.97 0.90 1.27® 0.74 
^Replicate 
^Replicate 
< 0.01. 
*^P < 0.05. 
®P < 0.10. 
T, n=3.89. 
II, n=3.78. 
t 
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Except for the interaction of session and dietary methionine, the 
rest of the session interactions with other factors had significant effects 
on one or two of the variables in one of the replicates with the proba­
bility level of P<0.01 to P<0-10 (see Tables 34 and 35). Only the ATCR 
variable in both replicates showed a significant effect of session, 
dietary methionine and atrazine interactions (Table 35). 
Since most of the session effects on variables were highly significant, 
the average values of Vcuriables of each session from different treatments 
were plotted in Figures 7 to 10. Figure 7 shows that, by increasing 
the number of sessions the average number of CR of rats in both replicates 
to the two-choice form stimuli significantly increased and that of the 
IR decreased-
The average number of defaults of rats in all treatments decreased 
until the 9th session. From the 9th to the 15#1 session defaults plateau, 
after which they increase slightly (Figure 8). 
The mean TTCR and TTIR of rats to the two-choice form stimuli are 
shown in Figure 9. The TTCR significantly increased and the TTIR 
decreased as the number of sessions increased. Only in replicate II did 
the mean of ATCR and ATIR show significant decrease as the number of 
sessions increased (Figure 10). 
The means of each variable across 14 sessions are shown in Tables 
36 to 41. LSD for the mean CR of rats in 14 sessions revealed that in 
replicate I, rats fed diet A and atrazine, had a significant increase 
of CR as compared with rats given only diet A (Table 36). In replicate 
II, there was also a significantly lower CR in rats fed diet C, plus 
atrazine, and treated with MeHg^ as compared with rats fed diet C 
correct responses 
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Figure 7. Change of average number of correct and incorrect responses of rats 
across all treatments in replicates I and II 
U) 
+J 
replicate 
replicate I 
9 11 13 15 17 
Number of Training Sessions 
Figure 8. Change of average number of defaults of rats across all treatments in replicates 
I and II 
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Figure 9. The change of mean of total time for correct and incorrect responses of rats 
across all treatments in replicate I and II 
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and atrazine (Table 36). 
Table 37 shows that in replicate I feeding rats atrazine and diet 
A caused a significant decrease of IR for all doses of MeHg, and feeding 
groups of rats diet A without atrazine, resulted in a significantly 
higher IR in comparison with the groups fed diets B or c without 
atrazine but treated with MeHg. In replicate II, feeding atrazine to the 
rats resulted in a significant increase of IR in groups fed diet B and 
treated with either MeHg^ or MeHg^- There was also a significantly 
higher IR in comparison with groups fed alike but treated with MeHg^ or 
MeHg^. In replicate II, there was also a significant increase in IR 
by rats given diet A without atrazine and treated with MeHg^ as compared 
with rats given only diet A (Table 37). 
Comparisons of the mean number of defaults in replicate I indicated 
that there were no significant differences among the means as a result of 
treatments (Table 38). However, replicate II showed that the number of 
defaults was significantly decreased by administration of atrazine in 
the diet of the group which received diet B or C with no MeHg treatment. 
The mean number of defaults in replicate II was decreased significantly 
by the higher dose of MeHg in the group of rats fed diet B without 
atrazine, but it increased with increasing dose of MeHg in the groups 
receiving diet C and atrazine (Table 38). 
Table 39 shows that in replicate I rats fed atrazine had a significant 
increase in mean TTCR when given diet A and MeHg^ or MeHg^. In replicate 
II, there was a significant increase of mean TTCR in rats fed diet B and 
treated with MeHg^ in comparison to rats receiving diet B only. 
u 0) 
w 
Cr> 66 
o 
o 
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Figure 10. The change in the mean of the average total time for correct and incorrect 
responses of rats in replicates I and II across all treatments 
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Table 36. The effect of dietary methionine, methylmercury hydroxide 
and atrazine on the mean number of correct responses of rats 
in the 14 testing sessions of each replicate (replicate I: l 
;LSD=1.62, n=3.89; replicate II: LSD=1.42, Ii=3.78) 
Toxicant 
Diet A 
Rep I Rep II 
Diet B 
Rep I Rep II 
Diet C 
Rep I Rep II 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
20.73 21.67 
22.78 21.85 
21.39 22.30 
22.21 22.51 
20.46 21.33 
21.05 22.51 
20.50 19.33 
21.00 22.89 
20.83 22.33 
20.23 22.02 
21.14 21.64 
22.03 22.12 
21.19 20.98 
20.67 21.98 
22.30 20.67 
21.55 20.80 
20.76 21.58 
21.46 19.89 
^MeHgj.=0.0 mg, MeHg2=0.5 mg, MeHg2=1.5 mg/kg body weight, -Atrazine= 
0.0 mg, TAtra2ine=500 mg/kg dier. 
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Table 37. The effect of dietary methionine, methylmercury hydroxide 
and atrazine on the mean number of incorrect responses of 
rats in the 14 testing sessions of each replicate (replicate I: 
LSD=1.43, n=3.89; replicate II: LSD=1.35, n=3.78) 
Toxicant 
Diet A 
Rep I Rep II 
Diet B 
Rep I Rep II 
Diet C 
Rep I Rep II 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
19.39 17.85 
17.98 18.82 
19.87 18.57 
17.73 17.92 
19.51 19.07 
17.41 19.01 
17.69 15.48 
18.78 18.35 
18.60 16.62 
18.26 18.62 
17.51 18.64 
18.82 17.80 
17.60 18.57 
17.46 19.19 
17.45 18.50 
18.46 17.78 
17.37 18.58 
17.85 18.01 
^MeHg^=0.0 mg, MeHg2=0.5 mg, MeHg^sl.S mg/kg body weight, -Atrazine= 
0.0 mg, +Atfazine=500 mg/kg diet. 
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Table 38. The effect of dietary_methioni,ne, methylmercury hydroxide 
and atrazine on the mean number of defaults of rats in the 
14 testing sessions of each replicate (replicate I: LSD=2.14, 
n = 3.89; replicate II: LSD=1.93, n=3.78) 
Toxicant 
Diet A 
Rep I Rep II 
Diet B 
Rep I Rep II 
Diet C 
Rep I Rep II 
MeHg^ 
-Atrazine 1.84 2.44 3.78 7.14 3.11 2.44 
+Atrazine 1.23 1.32 2.21 0.75 3.86 0.80 
MeHg^ 
-Atrazine 0.73 1.12 2.55 3.04 2.24 2.80 
+Atrazine 2-07 1.55 3.56 1.31 1.98 3.30 
MeHg^ 
-Atrazine 1.87 1.57 3.21 1.69 3.86 1.78 
+Atrazine 3.52 0.42 1.11 2.07 2.64 4.07 
^eHg.=0.0 rag, MeHg2=0.5 mg, MeHg^=1.5 mg/kg body weight, -Atrazine= 
0.0 mg, +Atrazine=500 mg/kg diet. 
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Table 39. The effect of dietary methionine, methylmercury hydroxide 
and atrazine on mean,.total time (x 1/10 sec.) for correct 
response of rats in the 14 sessions of each replicate 
(replicate I: LSD=110.7, n=3.89; replicate II; LSD=103.4, n=3.78) 
Toxicant 
Diet A 
Rep I Rep II 
Diet B 
Rep I Rep II 
Diet C 
Rep I Rep II 
MeHg^ 
-Atrazine 1371 1450 
+Atrazine 1494 1527 
MeHg^ 
-Atrazine 1362 1507 
+Atrazine 1478 1494 
MeHg^ 
-Atrazine 1364 1420 
+Atrazine 1467 1469 
1411 1349 
1403 1505 
1402 1512 
1336 1531 
1424 1434 
1435 1492 
1431 1423 
1417 1385 
1534 1399 
1435 1425 
1361 1430 
1381 1300 
^MeHg2=0.0 mg, MeHg2=0.5 mg, MeHg2=1.5 mg/kg body weight, -Atrazine= 
0.0 mg, +Atrazine=500 mg/kg diet. 
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TaJole 40. 
Toxicant 
The effect of dietary methionine, methylmercury hydroxide 
and atrazine on the mean average time (x 1/10 sec.) for 
correct response of rats in the 14 testing sessions of each 
replicate (replicate I: LSD=3.73, n=3l89; replicate II: 
LSD=3.40, n=3.78) 
Diet A 
Rep I Rep II 
Diet B 
Rep I Rep II 
Diet C 
Rep I Rep II 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
MeHg^ 
-Atrazine 
+Atrazine 
66.45 66.53 
65.78 69.83 
63.72 67.66 
67.05 66.84 
65.51 66.92 
69.07 65.19 
69.12 71.99 
67.10 65.83 
66.33 68.34 
64.25 69.42 
66.76 66.85 
65.50 67.67 
68.61 68.63 
68.05 63.19 
68.78 66.74 
65.99 70.24 
65.28 67.02 
64.24 62.15 
MeHg,=0.0 mg, MeHg,=0.5 ing, MeHg^=1.5 mg/kg body weight, -Atrazine= 
0.0 mg, +Atrazine=500 mg/kg diet. 
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Because the split plot factorial analysis of variance indicated no 
significant effect of treatments on TTIR (Table 35), mean comparisons 
on TTIR were not conducted. 
In replicate I, rats fed diet C and treated with MeHg^ had a 
significant increase of mean ATCR in comparison with those fed diet A 
and treated with MeHg^ (Table 40). In replicate I, rats treated with diet 
C, atrazine and MeHg^ also showed a significant decrease in mean ATCR in 
canparison with rats fed diet A, atrazine and treated with MeHg^. The 
mean ATCR in replicate II, was significantly higher for rats receiving 
diet B without atrazine and MeHg in comparison with those fed diets A 
or C (Table 40). In replicate II, rats fed diet A and atrazine showed 
a significantly higher ATCR compared with groups treated alike and given 
either diet B or C. In replicate II, also, groups given diet C, atrazine 
and MeHg^ showed a significantly higher meem ATCR in comparison with rats 
fed diet A, atrazine and treated with MeHg^ (see Table 40). 
Rats receiving diet B, atrazine and MeHg^ in replicate II showed a 
significantly higher mean ATCR in comparison to those treated with diet 
C, atrazine and MeHg^ (see Table 40). Atrazine caused an increase of 
ATCR in rats treated with diets B or C and resulted in a decrease 
of ATCR in those fed diet A (see Table 40). Atrazine in replicate II 
also resulted in a decrease of ATCR in the group fed diet C and treated 
with MeHg2* 
In replicate I, there was a significant decrease of mean ATIR 
due to atrazine in rats which were fed diet B with no MeHg treatment (Table 
41). The MeHg^ treatment in replicate I resulted in a decrease of mean 
ATIR in the rats fed diet C (Table 41). Rats fed diet C without atrazine 
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Table 41: The effects of dietary methionine, methylmercury hydroxide 
and atrazine on the mean average time (x 1/10 sec.) for the 
incorrect responses of rats in the 14 testing sessions of 
each replicate (replicate I: LSD=3.60, n=3.89; replicate II: 
LSD=3.05, n=3.78) 
Diet A Diet B Diet C 
Toxicant^ Rep I Rep II Rep I Rep II Rep I Rep II 
MeHg^ 
-Atrazine 66.77 66.15 69.58 71.67 69.20 67.69 
+Atrazine 66.80 69.00 65.92 65.41 67.41 63.07 
MeHg^ 
-Atrazine 64.07 65.95 65.86 66.95 69.72 65.77 
+Atrazine 67.52 65.86 64.26 67.38 67.78 67.93 
MeHg^ 
-Atrazine 66.05 64.84 68.04 67.34 68.25 66.13 
+Atrazine 68.14 63.63 66.46 66.62 65.22 63.99 
®MeHg^=0.0 mg, MeHg =0.5 mg, MeHg2=1.5 mg/kg body weight, -Atrazine= 
0.0 mg, +Atrazine=500 mg/kg diet. 
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but treated with MeHg^ showed a significantly higher mean ATIR in 
comparison with those treated with diet A or C, MeHg^ and no atrazine 
(Table 41). In replicate II, atrazine caused a decrease of mean ATIR 
in rats receiving diet B or C (Table 41). In the same replicate, rats 
fed only diet B showed a significantly higher mean ATIR compared to 
those fed only diet A or C (see Table 41). In replicate II, the groups 
treated with diet A, atrazine and no MeHg showed significantly higher 
mean ATIR than those treated with diet B or C and atrazine. A higher 
mean ATIR was observed for rats given diet B, atrazine, and MeHg^ compared 
to groups fed diet A, atrazine, and MeHg^ (see Table 41). 
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DISCUSSION 
Since methionine (Met) is one of the essential sulfur amino acids 
which has an important role in protein, S-adenosylmethionone, cystathionine, 
cysteine, and glutathione synthesis, its dietary supolementation might 
play an important role in the metabolism of nutrients and toxicants. It 
has been shown that addition of small amounts of DL-Met into a casein-
based diet improves growth rate, while further addition results in inhib­
ition of protein utilization in rats (Harper et al., 1970). Thus, 
dietary Met has a narrow margin of safety and it is known to be one of 
the most toxic amino acids. 
In our experiment, the results of weight gains of rats in response 
to different diets and toxicants indicates a role of detoxification 
capability for excess dietary Met on MeHg and atrazine toxicity. Low 
weight gain due to the consumption of Met deficient diet (diet B) occurred 
as expected. This is in agreement with the finding of Edes et al. (1979), 
who reported no weight gain in the rats fed a diet free of Met and cysteine. 
However, in this experiment the excess Met at the level of 24% above 
the requirement (diet C) did not cause toxicosis or beneficial weight 
gain increases in comparison to adequate Met diet (diet A) . Both the 
MeHg and atrazine caused lower weight gains. Similar results following 
the repeated administration of MeHg have been reported by Mivakawa and 
Deshimaru (1969). For MeHg toxicosis, the excess Met in the diet 
showed some protective effect. Improved weight gains in rats fed 
excessive Met in the diet and treated with atrazine or MeHg^ alone or 
atrazine and MeHg^, are to some degree supportive of the protective 
effect of excess Met against atrazine as well as against MeHg. When 
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atraizine and MeHg^ were administered to the rats the excess Met diet 
did not protect animals from the weight loss of rats fed the Met 
deficient diet with atrazine and MeHg. The high Met rats lost more weight 
than those fed the Met adequate diet and both toxicants 
Glutathione conjugation is probably one of the important mechanisms 
of detoxification of both MeHg and atrazine in the rat. The glutathione 
conjugation process does not require the initial formation of high 
energy intermediate involving ATP; the synthesis of glutathione (GSH) 
from its component amino acids and N-acetylation of cysteine conjugate 
does utilize ATP (Chasseaud, 1976). In this experiment, in the course 
of repeated e:gosure of rats to the toxicants, conversion of Met to 
cysteine through the cystathionine pathway and biosynthesis of GSH are 
possibly stimulated. Thus, disruption of normal Met and cysteine 
metabolism and increased utilization of energy and the sulfur amino acids 
for glutathione synthesis and excretion of toxicants are possible 
explanations for the limited protective effect of excess Met in the diet 
and the loss of body weight in rats due to toxicants and/or the Met 
deficient diet. 
The liver and kidney are the major sites of detoxification for most 
xenobiotics. Atrazine in rats has been shown to be conjugated with GSH 
and excreted through urine or bile (Dauterman and Mueeke, 1974; Climie 
and Hutson, 1979) . Etie conjugation of MeHg with GSH and cysteine also 
occurs in liver and the conjugate is excreted either through bile or 
urine (Norseth and Clarkson, 1971). The liver and kidney also accumulate 
mercury to a great extent by conjugation to metallothionein, membranes 
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or other available -SH groups fPiotrowski. et al., 1974; Winge et al., 
1975). Thus, increases in the activity and induction of enzymes or metal-
lothionein or proliferation of membranes or cells in response to atrazine 
and MeHg toxicity might result in weight change of these organs. A 
change in proportional liver weight due to feeding a Met deficient diet 
alone was not observed in this experiment. Similar results were obtained 
by Edes et al. (1979) . The increase of liver weight due to MeHg toxicity 
has been demonstrated previously by Chang and Desnoyers (1978). Considering 
the liver weight increases as a response of rats to both toxicants, 
alone or in combination, the groups fed Met deficient or adequate diets 
showed significant increases in liver weight, whereas the groups fed Met 
excess diet did not show such a significant increase. Again such 
results support the protective effect of excess dietary Met agëiinst liver 
damage by MeHg and atrazine. 
Orme stead et al. (1980) stated that drugs conjugated with GSH in 
the liver are further metabolized to the corresponding cysteine derivatives 
in the kidney. In this experiment, the response of the kidney to detoxi­
fication of atrazine and MeHg was manifested by an increase in kidney 
weight. The drastic increase of kidney weight due to the high level of 
mercury (MeHg^) may be partly due to the induction of metallothionein 
after the biotransformation of MeHg to inorganic mercury. The increase 
of inorganic mercury and induction of metallothionein in kidney after 
MeHg exposure to rats has been shown previously in the rat (Chmielnicka 
and Brzeznicka, 1978). In the kidney, the protective effect cf excess 
Met was not as clear as in the liver. This might be due to the fact 
that the kidney was more responsible for the detoxification of both 
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toxicants, compared to the liver. Only the Met excess diet caused a 
significant small increase in kidney weight in rats treated with MeHg^ 
when compared to the other two levels of Met in the diet. Dietary Met 
alone had no effect on kidney weight. 
The accumulation and concentration of mercury in the organs and 
tissues depends on the type of mercury compound, dose, duration of 
exposure, age, health of the rat and the time of sampling after the last 
administration of mercury. Injection of a single dose of MeHg in mice 
and rats has been shown to result in an accumulation of mercury in kidney, 
blood, and liver in that order (Ulfvarson, 1959a; 1969b). In addition, 
the administration of a total dose of 40 mg MeHg per kg of body weight 
in three days to rats resulted in an accumulation of mercury after 19 
days in blood, kidney, liver and brain. Since longer exposure (five weeks) 
of MeHg were used in our experiment, and mercury concentrations were 
measured in the samples prepared a day after the last exposure, the 
order of mercury concentration in the tissues is in agreement with 
those of Ulfvarson (1959b). The blood had the highest and the brain 
had the lowest concentration of mercury. 
In rats, a major portion of the circulating blood MeHg is bound 
in erythrocytes, mainly to hemoglobin (Chen et al., 1975). In humans 
and rabbits, however, it is mainly bound to glutathione rather than 
to hemoglobin (Naganumra and Imura, 1979). Therefore, the change of 
blood GHS in the rat should not affect the blood mercury concentration 
extensively. Also, we did not find any correlation between blood 
mercury concentration and blood GSH in this experiment. 
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Nevertheless, the data on organ and tissue concentrations of 
mercury are rather difficult to interpret. Obviously, the concentration 
of mercury in the organs is highly influenced by the dose of MeHg; an 
increase of mercury concentration in the organs resulted from administra­
tion of high dose of MeHg. Also, administration of atrazine caused more 
accumulation of mercury in the liver of rats treated with MeHg^, but it 
is not possible to draw any conclusion regarding the influence of dietary 
Met on mercury deposition in the organs. 
From the works of Ulfvarson {1969b) and Cember and Donagi (1964) 
on the distribution and elimination of organic mercury compounds by rats, 
calculations can be made based on the two following criteria which will 
help to evaluate the effect of dietary Met on MeHg deposition in the 
organs. 
1. The concentration of mercury in the kidney at all dose levels 
is a constant fraction of mercury retained in the body (Cember 
and Donagi, 1954). Therefore, concentrations of mercury in 
blood, liver and brain relative to kidney mercury, indicate 
the degree of toxicity or accumulation of mercury in the organ. 
This is calculated as: Ratio A = (Hg conc. tissue) 4- (Hg conc. 
kidney). 
2. The ratio of relative concentrations of mercury in the organs 
should be similar among the groups treated alike. This was 
calculated as: Ratio B = (Ratio A for MeHg^ treated animals) ? 
(Ratio A for MeHg^ treated animals). Therefore, any differences 
seen in the present study would be either due to dietary 
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methionine or atrazine treatments. 
The relative concentrations of Hg in the blood, liver, and brain to 
that of the kidney (Ratio A) are shown in Tables 42 and 43- Dividing 
data from Table 42 by data in Table 43 gives the ratios in Table 44 (Ratio 
B) . 
Relatively more mercury was accumulated in the blood and brain than 
in the liver with either dose of mercury (Tables 42 and 43). The effect 
of dietary Met is shown clearly in Table 44. Feeding the Met deficient 
diet resulted in a distinctly greater accumulation of mercury in the 
organs: The Met deficient diet tended to accentuate the accumulation of 
mercury in the brains of rats fed either MeHg^ or MeHg^ levels. The 
protective effects of excess Met in the diet were not distinguishable 
from the effect of the adequate diet with regard to the accumulation of 
mercury in the organs. There was no consistent effect of atrazine on these 
values. The effects shown in Table 44 are illustrated in Figure 11. 
Although brain accumulated a higher amount of mercury in the group 
fed the Met deficient diet, the onset of clinical manifestations of MeHg 
neurotoxicity in this group was not different from those of the rats fed 
the adequate or excess Met diet. This might be due to the fact that in the 
rat the first observable damage occurs in the peripheral nervous system 
and in cerebellum rather than in sensory cerebral cortex (Evans et al., 
1975). In this experiment, despite the effect of atrazine on liver 
mercury concentration, it did not affect the brain mercury concentration. 
Clinically, however, the onset of MeHg neurotoxicity signs started 
earlier in the groups fed atrazine in the diet. This discrepancy might 
also be explained in the same way as the effect of mercury on peripheral 
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Table 42. Relative mercury concentration of blood, liver, and brain 
to kidney in the rats treated with low mercury dose (MeHg, 
0.5 mg/kg) ^ 
Diet A Diet B Diet C 
-Atr. +Atr. -Atr. +Atr. -Atr. +Atr. 
Hg blood/ 
Hg kidney 1.94 1.90 1.09 1.53 1.42 1.35 
Hg liver/ 
Hg kidney 0.24 0.29 0.22 0.24 0-19 0.23 
Hg brain/ 
Hg kidney 0.07 0.09 0.09 0.6 0.07 0.09 
Table 43. Relative mercury concentration of blood, liver, and brain 
to kidney in rats treated with high mercury dose (MeHg2= 
1.5 mg/kg) 
Diet A Diet B Diet C 
-Atr. 4-Atr. -Atr. +Atr. -Atr. +Atr. 
Hg blood/ 
Hg kidney 2.94 2.86 3.67 4.92 3.14 3.01 
Hg liver/ 
Hg kidney 0.46 0.70 0.65 0.72 0.46 0.76 
Hg brain/ 
Hg kidney 0.24 0.29 0.30 0.30 0.23 0.26 
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Table 44. Ratio of the relative mercury concentration of tissues to 
kidney at the high mercury (MeHg^) treatment to the low 
mercury (MeHg2) treatment 
Diet A Diet B Diet C 
-Atr. +Atr. -Atr. +Atr. -Atr. +Atr. 
Hg blood/ 
Hg kidney 1.51 1.50 3.37 3.21 2.21 2.23 
Hg liver/ 
Hg kidney 1.92 2.41 2.95 3.00 2.42 3.30 
Hg liver/ 
Hg kidney 3.31 3.24 5.24 4.60 3.02 2.91 
nervous system rather than on the cerebral cortex. 
The excretion of mercury in urine increased as the cumulative 
dose of MeHg (total dose of ej^osure at the time of urine collection) 
increased. The results of this study showed that toxicity of atrazine 
in rats had no effect on urine excretion of mercury after stimultaneous 
treatment of rats with atrazine and MeHg for a week. However, atrazine 
significantly affected mercury excretion in urine collected during period 
II (after 3 weeks of treatments). No effect of atrazine on urine mercury 
excretion was seen during period III. This might be due to the cumulative 
toxicity of MeHg which overcame the effect of atrazine toxicity and, 
consequently an atrazine effect was not detected during period III. 
Mercury content of urine samples might also be subjected to the errors 
of the urine collection method. Technically the collection of urine by the 
method of Black and Claxton (1979), in aluminum foil may be only applicable 
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Figure 11. The effects of dietary met on the ratio of relative 
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ment (• and o=Hg blood/Hg kidney, # and a =Hg liver/Hg 
kidney, • and A =Hg brain/Hg kidney. Solid and hollow 
symbols are related to groups with and without atrazine 
treatments respectively) 
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to a short time urine collection and may not be suitable for the long 
period (12-14 hours) collection as was done in this experiment- Although, 
as suggested in the method, many wrinkles were made in the aluminum 
foil, and food was not provided uring urine collection, the evaporation 
of urine and contamination with feces and food particles carried on the 
fur of the rat remain major problems associated with this method. Since 
mercury is also excreted through the feces, the contamination of urine 
with feces in the collecting cages might contribute to the urine mercury 
concentration. Use of metabolic cages, if available, would be desirable 
for large numbers of animals and long term urine collection. 
The interaction between selenium and mercury has been shown in rats 
and other animals. The possible interaction between Se and Hg through the 
effect of selenium on the activity of the selenoenzyme, GSH-Px, was of 
particular interest in this experiment. The biochemical function of GSH-
Px in reduction of hydrogen peroxide as well as organic hydroperoxides 
is of critical importance in the erythrocyte (Sunde and Hoekstra, 1980). 
This enzyme may be required in the metabolism of arachidonate and in 
prostaglandin synthesis (Anonymous, 1981). In this study, administration 
of MeHg caused a significant reduction in the activity of whole blood 
GSH-Px of rats. This reduction of activity was related directly to the 
dose of MeHg administered. The enzyme activity reduction by MeHg might be 
related to the complex formation of MeHg with the biologically active SE 
of GSH-Px as has been speculated by Hoekstra (1975) and Ganther (1975). 
In the present study, the activity of whole blood GSH-Px in the rat 
declined as the concentration of mercury in the blood increased as a 
result of high MeHg treatment. Such Hg and GSH-Px relationship existed 
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in the blood of rats fed either of the dietary Met levels. Although 
statistical analysis did not show any significant influence of dietary Met 
on the whole blood GSH-Px; however, considering Table 44, one can infer 
some effect of low Met diet (B) on the increase of blood mercury 
concentration, and consequently its effect on the depression of whole 
blood GSH-Px activity. 
It is rather difficult to draw a clear conclusion on the overall 
effect of treatments on liver GSH-Px activity. Despite the increase in 
mercury concentration of liver by the higher dose of MeHg, the specific 
activity of Se-dependent GSH-Px remained unchanged. The inhibitory 
effect of MeHg observed with blood GSH-Px was not seen with liver GSH-Px. 
To calculate the specific activity of GSH-Px of liver, the total liver 
protein was measured. The inhibitory effect of mercury on protein 
synthesis in liver might have caused the above mentioned unexpected results. 
The activity of the enzyme was also decreased by the Met deficient diet. 
However, this kind of effect was not significant for all groups receiving 
Met deficient diets. 
The specific activity of GSH-Rd in liver did not change significantly 
in any of the treatments. This confirms the finding of Pekkanen and 
Sandholm (1972) that showed liver GSH-Rd activity was not affected by MeHg. 
Use of 1,2-dichloro-4-nitrobenzene conjugation with GSH is a valid 
model to evaluate liver ccsapetence for the initial step in the mercapturic 
acid synthesis for atrazine detoxification. Therefore, the cytosolic 
glutathione-S-transferase of liver was investigated. It was found that 
long term exposure of atrazine causes reduction of specific activity of 
this enzyme in rat liver. It seems that increasing MeHg dose causes 
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a decrease of specific activity of GSH—S-trans in rats fed Met deficient 
diets, but an increase of specific activity was causée?, in the rats fed 
Met imbalanced diets (Met deficient or Met excess). The overall 
picture does not indicate that feeding rats Met excess diet will result 
in a greater liver competence with respect to conjugation of atrazine 
with GSH, by GSH-S-trans. The biochemical inhibitory effects of atrazine 
and MeHg on specific activity of liver GSH-S-trans need further investi­
gation . 
Prostaglandins (PCs) are fundamental response metabolites of cells 
or organisms. Synthesis of PCs depends on regulation of essential fatty 
acid metabolism, lipase activity, cofactors, hormones and other factors. 
Metabolism of glutathione, vitamin E, Met, and GSH-Px activity may 
influence the PGs synthesis (Tai and Yuan, 1977; Nugteren, 1970; Lands 
and Rome, 1976; Horrobin et al., 1978; Morse et al., 1977). In this 
experiment, ex-vivo synthesis of PGE^ and TXB^ by platelets from clotted 
blood were higher in the groups treated with MeHg. There are no previous 
reports of effect of MeHg on synthesis of PGs. Several factors might be 
responsible for the increase of PG synthesis in blood. With the available 
data, the most logical speculation might be the possible reduction of 
activity of GSH-Px of blood by MeHg. Since hydrogen peroxide and organic 
hydroperoxides have stimulatory effects on PG synthesis, the increase of 
PGs in this experiment might have resulted from a build up of some 
endogenous hydroperoxides by the decrease of GSH-Px activity in the blood. 
The effects of hydroperoxy free radicals or peroxy radicals on endoperoxide 
formation and PG synthesis are described by Morse et al. (1977). A 
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decrease in availability of vitamin E might also have contributed to 
increased PG synthesis. Vitamin E as an antioxidant plays an important 
role in membrane stabilization. Vitamin E has also been shown to have 
a protective effect against MeHg toxicity (Welsh, 1974; Siinde, 1976; Chang 
et al., 1977). The inhibitory effect of vitamin E on biosynthesis of PGs 
has been established (Nugteren, 1970; Lands and Rome, 1975). Such an 
inhibitory effect might result from its antioxidant activity. Considering 
the above effects, MeHg toxicity in the rats might have resulted in a 
decline of vitamin E concentration which consequently caused an enhance­
ment of biosynthesis of PGs. The level of vitamin E in the diet of rats 
in this experiment was at the minimum requirement for the rat as indicated by 
NRC/NAS (1978). Decrease of PGE^ synthesis in brain by excess Met 
through taurine metabolism has been suggested (Horrobin et al., 1978). 
In this experiment, although dietary Met showed an influence on both PGE^ 
and TXB^ ex-vivo synthesis in clotted blood, the effects were not clear 
enough to be in agreement with the suggestions of Horrobin et al. (1978). 
Administration of xenobiotics subject to GSH conjugation may lead 
to extensive depletion of cellular GSH (Wood, 1970; Chasseaud, 1973; 
Gillette, 1977). It has been shown that deposition of MeHg in liver was 
not affected when liver GSH was depressed to 15% of control after 30 min. 
of administration of diethylmaleate in rat (Richardson and Murphy, 1975). 
But depletion of blood and kidney GSH were correlated to lower depositions 
of mercury in the same experiment. Congiu et al. (1979) found that 
administration of MeHg chloride to rats resulted in an increase of liver 
GSH and a decrease of kidney GSH, without any increase in mercury concen­
tration in liver. The results of our experiment are somewhat different 
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from those- Although it has been shown that atrazine is conjugated with 
GSH by the enzyme GSH-S-trans (Dauterman and Muecke, 1974; Climie 
Hutson, 1978), feeding rats with atrazine in the amount of 500 mg/kg of 
diet ad libitum for five weeks, did not cause any change in liver GSH 
levels. However, atrazine caused an increase in the mercury deposition 
with high level of MeHg administration. Atrazine also caused a significant 
increase of GSH in blood, but blood mercury concentration was not signifi­
cantly affected. MeHg deposition in kidney and brain also did not change 
significantly with atrazine treatment. Administration of MeHg alone 
produced a slight numerical increase of GSH of liver by increasing the 
dose from MeHg^ to MeHg^, but it did not reach statistical significance. 
However, liver and kidney mercury deposition were greatly increased. 
These results also are not in agreement with Congui et al. (1979). 
Since GSH measurements of the organs in most experiments were 
conducted within short periods of time after exposure to GSH depleting 
agents (Griffith and Meister, 1979; Mitchell et al., 1973; James et al., 
1971; Boyland and Chasseaud, 1979), the development of tolerance by 
repeated exposure, presence of alternative detoxifying pathways and 
interorgan translocation of GSH might be the reason for lack of effect 
of atrazine on liver GSH concentration in this experiment. Development 
of tolerance to sodium maleate which decreases GSH has been demonstrated 
in rats by Richardson anà Murphy (1975). Although Refsvik (1978) inter­
preted that a high concentration of liver GSH is requisite for the normal 
translocation of MeHg from liver to bile, the result of the present 
experiment indicates that in long term exposure to MeHg other 
sulfhydryl containing compounds such as cysteine may be involved in 
123 
translocation because liver mercury concentration increased with 
increasing MeHg dose in this experiment. 
Dietary Met with or without administration of both toxicants had 
no effect on liver glutathione status, but Met deficient diet alone 
caused a decrease of GSH and increase of GSSG and TGSH in blood. Met 
deficient diet together with atrazine also caused increases of blood GSH, 
GSSG and TGSH. However, when both toxicants were administered, the effect 
of dietary Met on blood glutathione was not clear. 
The mercapturic acids in urine were estimated by measuring conjugated 
sulfhydryl groups after alkaline hydrolysis. Conjugated cysteine or 
any other conjugated -SH groups were not excluded by this measurement. 
Therefore, the measurement was a crude estimation of mercapturic acid 
derivatives in the urine. Thus, the effect of diet and toxicants on 
mercapturic acids excretion must be evaluated conservatively. In this 
study, the most predominant influence on urine mercapturic acids 
excretion was through atrazine treatment, which caused an increase in 
excretion. This finding is in accord with the view that atrazine is a 
percursor of mercapturic acids in the rat (Climie and Hutson, 1978). 
However, the increase of mercapturic acids excretion in urine was not 
accompanied by liver or blood glutathione decreases, as stated before. 
The effect of atrazine on increasing mercapturic acids excretion 
was also accompanied by increased excretion of mercury in the urine. 
During period II, the administration of low dose of mercury (MeHg^) with 
or without atrazine in the diet generally resulted in higher excretion of 
mercapturic acid in urine in comparison with MeHg^ (no mercury) and 
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MeHg^ (high mercury) treatments. During period III, the effects of low 
and high doses of MeHg with or without atrazine are not distinguishable 
from each other. The excretion of mercapturic acids in urine is accom­
panied by increase of mercury excretion until period II, but during 
period III, the mercapturic acids excretion declined while mercury 
excretion increased and became independent from mercapturic acids 
excretion. This is possibly due to the fact that between the third and 
fifth week of administration of toxicants, the kidney had developed a 
dysfunction. The increase in kidney weight might also be 
such dysfunction. Therefore, mercury leakage into the urine without prior 
conjugation may have occurred. 
The increase of mercapturic acids excretion during period II was 
seen in the urine in all treatments. Such an increase might be related 
partially to the excretion of endogenous -SH conjugated metabolites, 
such as steroids, prostaglandins, and quinones (Chasseaud, 1976; Chaud-
hari et al., 1978). 
Discussion of Behavioral Studies 
Performance of a rat in the exposure phase in response to the two-
choice light stimuli is highly dependent on its previous experience with 
light stimuli in the pre-e:^osure phase. The unsatisfactory responses 
of rats to the two-choice form light stimuli in the exposure phase might 
be due to the fact that the correct responses of rats to the light stimuli 
during the last two sessions in the pre-exposure phase were only 55-81% 
(23-34 correct responses from 42 trials; see Table 33) . 
125 
Daily treatments of rats with dietary Met and toxicants had no 
meaningful effect on performances of rats as measured by number of, or 
time for, correct and incorrect responses, and number of defaults in 
response to the two-choice form light stimulus. Despite significant 
clinical and biochemical effects of treatments, performances in response 
to the visual stimulus were not significant after 27 daily testing ses­
sions. Nevertheless, analysis of variance and mean comparisons revealed 
that, except ATCR variable which was affected in both replicates, the 
other variables were only affected in one of the two replicates (see 
Tables 34 and 35). Thus, combining of data from two replicates of 
behavioral studies might give a fallacious result. 
Although ATCR in both replicates was significantly (P<0.10) 
affected by testing sessions and interaction of Met and atrazine factors, 
the mean comparison revealed that the effects were different in 
the two replicates. Therefore, they were not combinable and in­
conclusive. The overall session effects on the performance of all 
groups of rats are shown in Figures 7 to 10. The performance of rats in 
response to the stimulus in general improves significantly with the 
repetition of session. The average time for both CR and IR decreases 
until the 9th session (see Figure 10). This might indicate that all of 
the rats in different groups were learning the two-choice form of light 
stimulus and were responding at a fast rate. However, after the 9th session 
the improvement in learning was gradually diminished. Similar trends are 
observable in Figure 8 for the number of defaults which decreases until 
about the 9th session. 
126 
Since MeHg accumulated to a great extent in CNS, the effect of two 
doses of MeHg {0.5 and 1.5 mg/kg body weight) was the major consider­
ation among the other treatments for the behavioral study. Although the 
occipital lobe of rats brain did accumulate a high concentration of mercury 
(see Table 10), visual pathways probably were not affected in this e^geri-
ment because MeHg in rat mainly effects the cerebellum and peripheral 
nervous system rather than the cerebral cortex (Evans et al., 1975). 
This might be an important explanation for the no-effect findings. Thus, 
more probably the visual pathway of the rats was less affected during the 
course of repeated exposures, or the effect was not detected by the two-
choice form discrimination test. Ataxia, the leg-crossing phenomenon 
and other clinical signs of MeHg toxicity were predominant in high 
exposure (1.5 mg/kg) animals. A replication of this study with path­
ological investigation would give greater information about the defects 
in the visual pathway in this study. 
Perhaps it would have been possible to see the effects of diets and 
toxicants by the two-choice form light discrimination test if the number 
of training sessions in the pre-exposure phase had been extended from 
20-26 sessions to 40-50 sessions and the number of testing sessions in 
the exposure phase had been extended from 25-29 to 90-120 sessions. 
However, such extensions were not possible in our experiment. Since 
extension of pre-exposure days would have caused the rats ro be signifi­
cantly older, achieving a Met deficient condition would have been less 
likely during the short exposure phase. Increasing the exposure days, 
at least for the rats treated with high level of MeHg, probably would have 
resulted in high mortality (death of rats in these groups started after 
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30 days of exposure of high level of MeHg). 
• An alternative explanation for the no effect findings would be that 
the subtle visual effect of MeHg toxicity was masked by a high motivation 
of rats by water deprivation, i.e., water deprivation resulted in a 
high motivation of the rats in both control and treatment groups to 
respond to the light stimulus. Such speculation might be repudiated by 
the evidence that the mean CR increased while the IR decreased in all 
treatments as the session number increased (Figure 7). 
The findings suggest that the two-choice form discrimination is not 
the prime choice of behavioral studies in rats for a short period of time. 
Other behavioral tests such as ambulation, rearing (Lown et al., 1977), 
T-maze learning (Post et al., 1973), swimming ability (Zenick, 1974), and 
active avoidance learning (Hughes et al., 1975) might be more suitable 
for the investigation of MeHg effect on the rat and its interaction with 
nutrients and other toxicants in short term studies. 
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SUMMARY 
The effect of dietary methionine (Met), a percursor of cysteine 
and glutathione, on the toxicity of methylmercury hydroxide (MeHg) and 
atrazine in male Wistar rats was investigated. Eighteen daily treat­
ments were arranged from combinations of three levels of dietary Met 
(diet A = 0.42%, diet B = 0.18%, and diet C = 0.56%), three levels of 
MeHg (MeHg^ = 0.0 mg, MeHg^ = 0.5 mg, MeHg^ = 1.5 mg/kg of body weight) 
and two levels of atrazine (-Atrazine = 0.0 mg and +Atrazine = 500 mg/kg 
diet) to which a total of 144 rats in two replicates (72 rats/replicate 
containing 4 rats/treatment) were randomly assigned. 
Rats of each replicate were trained for 20-26 sessions to respond 
to the computer generated light stimulus in the pre-exposure phase of 
the study (25-32 days). A two-choice form light discrimination test 
was conducted for 25-29 sessions to investigate behavioral effects of 
diets and toxicants on rats in the exposure phase (32-35 days). 
_ Atrazine was administered in the diets which were provided to the 
rats ad libitum, and a combined two-day dose of MeHg was administered 
to the rats by gavage every other day. For mercapturic acids and 
mercury analyses, urine of rats was collected three times, in two-week 
intervals between collection, beginning a week after the treatments 
were started. 
At the end of the experiment, rats were anesthetized with ether; 
samples of blood, liver, kidney, and brain were collected for glutha-
thione peroxidase (GSH-Px), glutathione reductase (GSH-Rd), glutathione-
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S-transferase (GSH-S-trans), total glutathione (GSH and GSSG), prosta­
glandin (PG) , and r'.ercury assays. 
Excess dietary Met had a protective effect on MeHg and atrazine 
toxicity in rats using weight gain as the index of toxicity. An increased 
weight loss was observed in the rats fed diet B and treated with MeHg 
and atrazine in this experiment. The onset of MeHg toxicity signs 
started earlier in the groups fed atrazine in the diet. Liver weight 
was increased in response to the toxicants in the groups of rats fed diet 
A or B but liver weight was not changed by exposure to toxicant in the 
groups fed diet C. The protective effect of excess Met content of diet 
C caused a significantly lower increase of kidney weight in the rats 
which were treated with MeHg^, in contrast with the two other diets. 
Blood had the highest and liver the lowest concentrations of 
mercury. Kidney accumulated more mercury than did brain in rats which 
were treated with MeHg^. The reverse effect was found when MeHg^ was 
administered. There was no correlation between blood mercury concentration 
and status of blood GSH. Feeding the Met deficient diet (B) resulted 
in a greater accumulation of mercury in blood, liver and brain. This 
effect was most pronounced in brain tissue. Atrazine treatment caused 
a significant increase in mercury excretion in urine after three weeks 
of exposure but its effect at the end of the experiment was not 
significant, suggesting adaptation. 
Activities of whole blood GSH-Px declined as the concentration 
of mercury in blood increased. The deficiency of Met in the diet may 
have caused the decline of GSH-Px through increases in blood mercury 
concentrations. Despite an increase in mercury concentration in liver. 
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liver GSH-Px and GSH-Rd were unchanged. The long-term exposure of rats 
to atrazine in this experiment caused reductions of liver GSH-S-trans 
activity toward 1,2-dichloro-4-nitrobenzene. Increase in MeHg dose 
caused a decrease in GSH-S-trans activity in the groups fed diet B while 
GSH-S-trans activity increased in rats fed Met imbalanced diets (B and C). 
Feeding rats with diet C did not result in a greater liver competence 
for atrazine and MeHg detoxification. 
Treatments with MeHg^ and MeHg^ resulted in increases in 
ex-vivo synthesis of PGE^ and TXB^ by platelets from clotted blood. The 
increase in PGs might have resulted from a buildup of some endogenous 
hydroperoxides because of a decrease of GSH-Px activity, or a decrease in 
the availability of vitamin E. 
Although it has been shown that atrazine can deplete the GSH 
reserves of the body, feeding rats 500 mg of atrazine/kg diet ad libitum 
for 5 weeks did not cause persistent changes in liver total GSH, but 
there was an increase in blood GSH. Administration of MeHg alone caused 
a slight increase of GSH in liver. The development of tolerance after 
repeated exposure and the presence of alternative detoxifying pathways 
and interorgan translocation of GSH might be the reasons for no effect 
of atrazine on liver GSH status. 
Dietary Met caused no effect on liver GSH and an increase in GSSG 
(oxidized glutathione) and total GSH in blood. It also caused an increase 
in GSH, GSSG and total GSH in blood when atrazine was present. Atrazine 
increased urinary mercapturic acids excretion, and the excretion was also 
particularly affected by the low dose of MeHg after three weeks of repeated 
exposure. The increased mercapturic acid excretion may have been related 
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to the endogenous conjugated metabolites such as steroids, prostaglandins, 
and quinones. 
Despite significant clinical and biochemical effects of treatments 
on rats, performance of rats after 27 trials with two-choice form light 
stimulus as measured by number of, or time for correct and incorrect 
responses and number of defaults was not significantly affected by the 
treatments. Although the occipital lobe of rats brains did accumulate a 
high concentration of mercury, an effect of MeHg on the visual pathway of 
rats was not detected by the two-choice form discrimination test after 
27 testing sessions. Instead peripheral nervous system and cerebellum 
were highly affected, as indicated by the presence of ataxia and the 
leg-crossing phenomenon. 
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